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Abstract 
 Hairpin pyrrole-imidazole (Py-Im) polyamides are programmable oligomers that bind the 
DNA minor groove in a sequence-specific manner with affinities comparable to those of natural 
DNA-binding proteins.  These cell-permeable small molecules have been shown to enter the 
nuclei of live cells and downregulate endogenous gene expression.  We complete here a library of 
27 hairpin Py-Im polyamides that bind 7-base-pair sequences of the general form 5’-
WWGNNNW-3’ (where W = A or T, N = W, G, or C).  A table of binding affinities and 
sequence contexts for this completed 27-member library has been assembled for the benefit of the 
chemical biology community interested in molecular control of transcription.  Quantitative 
fluorescence-based methods have been developed to determine the nuclear concentration of 
polyamide-fluorescein conjugates in cell culture.  Confocal laser scanning microscopy and flow 
cytometry techniques are utilized to plot calibration curves, from which the nuclear concentration 
can be interpolated.  Although confocal microscopy and flow cytometry generate disparate 
values, taken together these experiments suggest that the polyamide concentration inside the cell 
nucleus is lower than it is outside the cell.  To further our understanding of C-terminal tail linkage 
effects on sequence specificity, the equilibrium association constants of hairpin polyamide 
conjugates were measured by quantitative DNase I footprint titration experiments.  These results 
indicate that linkers and functional R groups on the tails of hairpin polyamide conjugates have 
recognition properties that should be considered in the design of these molecules to target DNA 
binding sites.  Furthermore, these β-alanine-C3-linked polyamide conjugates are shown to 
decrease hypoxia-inducible transcription of vascular endothelial growth factor (VEGF) in 
cultured HeLa cells.  In addition, polyamide conjugates designed to target the Oct4 octamer DNA 
element modulate the expression levels of Oct4-driven genes in P19 mouse embryonal carcinoma 
cells and R1 mouse embryonic stem (ES) cells. 
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Introduction
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1.1.  Deoxyribonucleic acid (DNA)
DNA is the biological macromolecule that encodes the genetic information 
necessary for life.  The molecule consists of four different bases on a phosphodiester-
linked deoxyribose sugar backbone.  The intertwined strands of two DNA molecules 
form a double helix with hydrogen bonds between the Watson-Crick base pairs such that 
thymine (T) pairs with adenine (A), and cytosine (C) pairs with guanine (G).  The structure 
of B-form DNA is a right-handed helix containing ten base pairs per turn, and the plane 
of each hydrogen-bonded base pair lies perpendicular to the helix axis.1,2  A wide major 
groove and a narrow minor groove line the helix and are available for binding (Figure 
1.1).2  The human genome contains roughly three billion base pairs that encode 20,000 
Figure 1.1.  The structure of DNA.  (left) The phosphodiester-linked deoxyribose backbone 
is shown in blue, and the Watson-Crick base pairs are shown in gray (PDB accession code: 
1YSA5).  (right) The chemical structures of the DNA bases thymine (T), adenine (A), 
cytosine (C), and guanine (G) are shown as hydrogen-bonded base pairs.40
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to 25,000 protein-coding genes.3  In addition to DNA sequences that code for proteins, 
genes are associated with regulatory regions that control transcription.  In the context of 
the living cell, DNA-binding proteins and the interactions between proteins modulate gene 
expression.4,5  
1.2.  DNA-binding small molecules
Nature has evolved a number of small molecules, including actinomycin, 
echinomycin, and calicheamicin, that bind to specifi c sequences of DNA.  Distamycin A and 
netropsin are A,T-binding oligopeptidic antibiotic drugs of bacterial origin whose structures 
contain three and two N-methylpyrrole (Py) carboxamide units, respectively.6-9  The X-
ray crystal structure of the 1:1 complex between netropsin and 5’-CGCGAATTCGCG-
3’ shows that the crescent-shaped natural product binds in the minor groove of B-form 
DNA by displacing water molecules on the spine of hydration.10,11  The NMR structure of 
the 2:1 complex between distamycin and 5’-CGCAAATTGGC-3’ indicates that the two 
distamycin molecules bind the central 5’-AAATT-3’ region in an antiparallel orientation 
with expansion of the minor groove relative to the 1:1 ligand-DNA complex.12  The 
structures of the 1:1 and 2:1 distamycin-DNA complexes are depicted in Figure 1.2.13,14  
1.3.  Recognition of the DNA minor groove by pyrrole-imidazole polyamides
A modular code for molecular recognition of the four Watson-Crick base pairs has 
been empirically determined using pyrrole-imidazole polyamides.15,16  These synthetic 
ligands recognize the chemical features presented in the minor groove of DNA as a form 
of digital readout  (Figure 1.3).  The N-methylimidazole (Im) analog of distamycin binds 
the fi ve base-pair sequence 5’-WGWCW-3’ (where W = A or T) by formation of a 2:1 
polyamide-DNA complex.17,18  The two ImPyPy molecules are stacked together as an 
antiparallel dimer in the DNA minor groove with Im paired unsymmetrically across from 
Py to recognize the G•C base pair.  Hydrogen bonding between the Im nitrogen and the 
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Figure 1.2.  Structures of distamycin A bound to DNA as 1:1 and 2:1 complexes (PDB 
accession codes:  2DND13 and 378D14). The DNA backbone is shown in blue, the base 
pairs are gray, and distamycin is shown in stick representation.  The chemical structures of 
distamycin A (top) and netropsin (bottom) are shown below the crystal structures.40 
exocyclic amine of guanine helps to confer specifi city for G•C over C•G, A•T and T•A.19 
In this way, the Im/Py pair recognizes G•C and the Py/Im pair codes for C•G, while the 
degenerate Py/Py pair does not discriminate between A•T and T•A.  To complete the task 
of recognizing all four Watson-Crick base pairs, N-methylhydroxypyrrole (Hp) was paired 
5Figure 1.3.  Molecular recognition of the minor groove of DNA.  (top) Minor groove 
hydrogen bonding patterns of Watson-Crick base pairs.  Circles with dots represent lone 
pairs of N(3) of purines and O(2) of pyrimidines, and circles containing an H represent 
the 2-amino group of guanine.  The R group represents the sugar-phosphate backbone of 
DNA.  Electron pairs projecting into the minor groove are represented as shaded orbitals. 
(bottom)  Binding model for the complex formed between ImHpPyPy-γ-ImHpPyPy-β-Dp 
and a 5’-AGTACT-3’ sequence.  Putative hydrogen bonds are shown as dashed lines.16
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6across from Py to recognize T•A over A•T.20-22  The X-ray crystal structure of the 2:1 
complex between ImHpPyPy and 5’-CCAGTACTGG-3’ provides structural verifi cation 
of the pairing rules (Figure 1.4).     
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Figure 1.4.  Crystal structure of the 2:1 complex formed between ImHpPyPy-β-Dp and the 
5’-CCAGTACTGG-3’ sequence (PDB accession code:  407D21).  Polyamides are shown at 
right in a ball-and-stick model, where a black circle represents Im, a red circle with an H 
represents Hp, a gray circle represents Py, a white diamond represents β-alanine, and a half 
circle with a plus represents Dp.  
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1.4.  Hairpin polyamide motif
The pre-organization of two polyamide subunits by a covalent linkage improves 
the binding affi nity and sequence specifi city of these ligands.23-26  While several different 
binding motifs have been explored, the hairpin motif provides excellent affi nity and 
specifi city for DNA and can be accessed through a facile synthetic route.23  In the hairpin 
motif, a γ-aminobutyric acid (γ) covalently links the carboxylic terminus of one polyamide 
with the amino terminus of the other.  Eight-ring hairpin polyamides bind their six base-
pair DNA match sequences with subnanomolar affi nities.27,28
Structural features of the hairpin motif contribute to sequence-specifi c DNA 
recognition (Figure 1.5).  The γ residue that forms the turn of the hairpin recognizes A•T 
and T•A base pairs.  A chiral 2,4-diaminobutyric acid improves affi nity while retaining 
specifi city for A•T and T•A.29  The increased binding affi nity can be attributed to electrostatic 
interactions between the negatively charged DNA backbone and the positively charged free 
amine on the turn.  Furthermore, the chiral turn allows stereochemical control, enforcing 
the N→C polyamide alignment with respect to the 5’→3’ orientation of the adjacent DNA 
strand.29,30
The microstructure of DNA is sequence-dependent, and polyamides composed of 
Py and Im rings are overly curved compared to the DNA minor groove.  Aliphatic β-
alanine residues have been incorporated at internal positions to reset the register between 
contiguous aromatic ring pairings.31  The β/Py and Py/β pairs, as well as the β/β degenerate 
pair, recognize A•T and T•A base pairs.31,32  The β-alanine residue on the tail, as well as 
the 3-(dimethylamino)propylamine (Dp) tail itself, both code for A•T and T•A.33  Hairpin 
polyamide design typically includes an Im/Py pairing at the hairpin N-terminus in order to 
impart G•C specifi city at this position.  However, when 3-chlorothiophene (Ct) is paired 
across from Py at the N-terminus, the Ct/Py pair exhibits specifi city for T•A.34   In this way, 
the eight-ring hairpin polyamide CtPyPyIm-(R)RHNγ-PyImPyPy-β-Dp recognizes the seven 
base-pair sequence 5’-WWTWCGW-3’ in the DNA minor groove.
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Figure 1.5.  Binding model for the complex formed between CtPyPyIm-(R)RHNγ-PyImPyPy-
β-Dp and a 5’-TATACGT-3’ sequence.  A ball-and-stick model is shown at bottom, where a 
blue square represents Ct, a black circle represents Im, a white circle represents Py, a white 
diamond represents β-alanine, a half circle with a plus represents Dp, and the chiral 2,4-
diaminobutyric acid turn residue is shown as a semicircle connecting the two subunits with 
a solid wedge linking a half-circle with a plus.  
Methods for solid-phase synthesis of hairpin polyamides have been developed 
using standard Boc coupling chemistry.35,36  Aminolysis furnishes the polyamide, which 
can be further derivatized on the turn or tail residues.  The selection of either β-Ala-PAM 
or Kaiser oxime resin yields different C-terminal groups following cleavage with a primary 
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Figure 1.6.  Synthesis of polyamides on solid support.  β-Ala-PAM resin and Kaiser oxime 
resin yield different C-terminal groups following cleavage with a primary amine.  Z = H, 
Ac, or Boc, if further derivatization is required.16  
amine (Figure 1.6).  The use of β-Ala-PAM resin leaves a residual A,T-specifi c β-alanine 
moiety at the C-terminus, while oxime resin produces a shorter polyamide.  Access to a 
diverse range of polyamide binding motifs and linkers has proven valuable for experiments 
in cell culture.  
1.5.  Nuclear localization of hairpin polyamide conjugates in cell culture studies
Confocal microscopy has been used to determine the uptake profi les of polyamide-
fl uorophore conjugates in a range of cell lines.37-40  A brief excerpt is presented in Figure 
1.7.  Polyamide 1 localizes to the nucleus, while polyamide 2 is excluded from the nucleus, 
which reveals that uptake is core-dependent.  Removal of the β-alanine residue to produce 
10
polyamide 3 rescues uptake, suggesting that the incorporation of β-alanine may be lethal for 
uptake.  The poor nuclear localization of polyamide 4 indicates that fl uorophore selection 
is crucial.41  Based on these results, fl uorescein has been the fl uorescent dye of choice in 
recent experiments.  
The gained insights into cellular uptake properties of polyamides have proven 
instrumental in the successful design of gene regulation studies.  A polyamide-fl uorescein 
conjugate has been shown to decrease hypoxia-inducible transcription of vascular 
endothelial growth factor (VEGF) in cultured HeLa cells.42,43  The binding of this polyamide 
to the hypoxia response element (HRE) disrupts the binding of hypoxia-inducible factor to 
the HRE.  Inhibition of VEGF expression has been used to assay the nuclear localization 
of HRE-targeted polyamides.  These studies have shown that the fl uorescein dye can be 
minimized to a isophthalic acid moiety, yielding higher-affi nity conjugates that exhibit 
comparable biological activity.44  A hairpin polyamide-isophthalic acid conjugate has been 
shown to downregulate prostate-specifi c antigen (PSA) expression in prostate cancer cells 
by binding the androgen response element in the PSA promoter.45  This prevents the binding 
of androgen receptor (AR) and inhibits androgen-induced PSA expression.  
Figure 1.7.  Uptake profi le of polyamide-fl uorophore conjugates 1-4 in 13 cell lines.38  ++ 
indicates that nuclear staining exceeds that of the medium; +, nuclear staining less than 
or equal to that of the medium, but still prominent; –, very little nuclear staining, with the 
most fl uorescence seen in the cytoplasm and/or medium; – –, no nuclear staining.38,39  In 
the ball-and-stick model, a black circle represents Im, a white circle represents Py, a white 
diamond represents β-alanine, “(+)” represents the 3,3’-diamino-N-methyldipropylamine 
linker, and a half-circle represents the γ-aminobutyric acid turn residue.
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1.6.  Scope of this work
In Chapter 2, we complete a library of 27 hairpin Py-Im polyamides that bind 
7-base-pair sequences of the general form 5’-WWGNNNW-3’ (where W = A or T, N = 
W, G, or C).  A table of binding affi nities and sequence contexts for this completed 27-
member library has been assembled for the benefi t of the chemical biology community 
interested in molecular control of transcription.  In Chapter 3, quantitative fl uorescence-
based methods have been developed to determine the nuclear concentration of polyamide-
fl uorescein conjugates in cell culture.  Confocal laser scanning microscopy and fl ow 
cytometry techniques are utilized to plot calibration curves, from which the nuclear 
concentration can be interpolated.  Although confocal microscopy and fl ow cytometry 
generate disparate values, taken together these experiments suggest that the polyamide 
concentration inside the cell nucleus is lower than it is outside the cell.  In Chapter 4, 
to further our understanding of C-terminal tail linkage effects on sequence specifi city, 
the equilibrium association constants of hairpin polyamide conjugates were measured by 
quantitative DNase I footprint titration experiments.  These results indicate that linkers 
and functional R groups on the tails of hairpin polyamide conjugates have recognition 
properties that should be considered in the design of these molecules to target DNA binding 
sites.  Furthermore, these β-alanine-C3-linked polyamide conjugates are shown to decrease 
hypoxia-inducible transcription of vascular endothelial growth factor (VEGF) in cultured 
HeLa cells.  In Chapter 5, polyamide conjugates designed to target the Oct4 octamer DNA 
element modulate the expression levels of Oct4-driven genes in P19 mouse embryonal 
carcinoma cells and R1 mouse embryonic stem (ES) cells.
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Chapter 2
Completion of a Programmable
DNA-Binding Small Molecule Library
The text of this chapter was taken in part from a manuscript co-authored with John W. 
Phillips, John W. Trauger, Michelle E. Farkas, Jason M. Belitsky, Alexander Heckel, 
Bogdan Z. Olenyuk, James W. Puckett, Clay C. C. Wang, and Peter B. Dervan (Caltech).
(Hsu, C. F., Phillips, J. W., Trauger, J. W., Farkas, M. E., Belitsky, J. M., Heckel, A., 
Olenyuk, B. Z., Puckett, J. W., Wang, C. C. C., Dervan, P. B. (2007) Tetrahedron 63, 6146-
6151.)
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Abstract
Hairpin pyrrole-imidazole (Py-Im) polyamides are programmable oligomers that 
bind the DNA minor groove in a sequence-specifi c manner with affi nities comparable to 
those of natural DNA-binding proteins.  These cell-permeable small molecules have been 
shown to enter the nuclei of live cells and downregulate endogenous gene expression.  We 
complete here a library of 27 hairpin Py-Im polyamides that bind 7-base-pair sequences 
of the general form 5’-WWGNNNW-3’ (where W = A or T, N = W, G, or C).  Their 
equilibrium association constants (Ka) range from Ka = 1×10
8 M-1 to 4×1010 M-1 with good 
sequence specifi city.  A table of binding affi nities and sequence contexts for this completed 
27-member library has been assembled for the benefi t of the chemical biology community 
interested in molecular control of transcription.
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2.1.  Introduction
The biological applications of sequence-specifi c DNA-binding small molecules are 
a subject of intense research but are still far from being routine.1-11  Py-Im polyamides 
have been shown to infl uence a number of protein-DNA interactions, demonstrating both 
repression and activation of gene expression.  Confocal microscopy experiments have 
confi rmed that polyamide-fl uorophore conjugates traffi c unaided to the nuclei of living 
cells.12-14  Since many diseases are attributed to aberrant gene expression, the regulation of 
transcriptional pathways with small molecules could have an important effect on human 
medicine.15-17  For researchers interested in selectively targeting protein-DNA interfaces in 
promoters of specifi c genes with small molecules, access to well-characterized libraries of 
polyamides which bind a repertoire of different sequences with high affi nity and specifi city 
could enable development in this area.
Polyamides constructed from N-methylpyrrole (Py), N-methylimidazole (Im), and 
N-methylhydroxypyrrole (Hp) amino acids comprise a class of synthetic ligands that bind 
within the minor groove of DNA in a sequence-specifi c manner.18,19  Inspired by the natural 
products netropsin and distamycin A, these programmed molecules recognize the Watson-
Crick base pairs (bp) according to a series of pairing rules, where aromatic heterocycles 
paired in an antiparallel fashion are able to discriminate one Watson-Crick base pair from 
the other three combinations.  The Py/Py pair recognizes A,T over C,G.20  The Im/Py pair 
distinguishes G•C from C•G.21,22  The exocyclic amine of guanine presents steric hindrance 
to the C3-H of Py, while the N3 of Im accommodates the amine and accepts one of its 
hydrogen bonds.  The Hp/Py pair discriminates T•A over A•T due to the steric fi t of the 
hydroxy group protruding into the minor groove, thus completing the pairing rules.23,24 
NMR and X-ray crystallography studies reveal that the crescent-shaped polyamide side-
by-side dimer binds B-form DNA, a remarkable example of shape-selective recognition of 
the deep minor groove of DNA.20,22,25,26
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Within the framework of the pairing rules, covalent linkages between two antiparallel 
polyamide strands result in several possible structures, including the hairpin, cycle, H-
pin, and U-pin binding motifs.27-30  These linked structures show improved affi nity and 
specifi city when compared with the unlinked dimers.  The eight-ring hairpin polyamide 
provides a good compromise between synthetic ease (linear vs. branched oligomers) and 
molecular recognition properties.  In this binding motif, a γ-aminobutyric acid residue 
connects the carboxylic terminus of one strand to the amino terminus of the other.27  The 
turn residue also serves as a DNA recognition element, as it has been shown to bind A•T 
and T•A base pairs with greater than 25-fold specifi city over C•G and G•C, presumably 
for steric reasons.31  Use of a chiral diaminobutyric acid turn residue increases the overall 
binding affi nity of the molecule by 10-fold without a loss of sequence specifi city.32
When hairpin polyamides are synthesized using solid phase methods on Boc-β-
Ala-PAM resin and cleaved with 3-dimethylamino-1-propylamine, the product contains a 
β-alanine residue and a dimethylaminopropylamide tail at the C-terminus.  Both of these 
elements are specifi c for W (where W = A or T) over G•C and C•G, again for steric reasons. 
In the hairpin motif, the β-alanine residue exhibits greater than 210-fold specifi city for 
A•T and T•A base pairs over G•C and C•G.31  The dimethylaminopropylamide tail shows a 
20-fold preference for A•T and T•A over G•C and C•G.31  Therefore, an eight-ring hairpin 
polyamide can bind seven base pairs with specifi city for W over the turn, β-alanine residue, 
and tail (Figure 2.1).
We have excluded Hp in this study in favor of more stable Py residue.  The 
electron-rich Hp ring degrades in the presence of strong acid and free radical impurities. 
Based on the paradigm of unsymmetrical ring pairings, more robust rings such as the 
hydroxybenzimidazole/Py pair can replace Hp for T•A recognition.33  In our work, hairpin 
polyamide design typically includes an Im/Py pairing at the hairpin terminus in order to 
impart G•C specifi city at this position.  As a result, eight-ring pyrrole-imidazole hairpin 
polyamides can specifi cally bind 7-bp sequences of the general form 5’-WWGNNNW-
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3’ (where N = W, G, or C).  There are 27 possible permutations that fall within these 
guidelines.  Our group has published the energetics of 11 hairpin polyamides binding 11 
distinct cognate sequences.  Over half of the 27 sequences remain unreported.  Searching 
our theses and notebooks confi rmed 7 additional previously unpublished characterizations. 
Our studies during the past decade left only 9 out of 27 sequences unexamined; these are: 
5’-WWGCGWW-3’, 5’-WWGCCWW-3’, 5’-WWGCWCW-3’, 5’-WWGCCCW-3’, 5’-
Figure 2.1.  (Top) Model for the complex formed between hairpin polyamide 24 and its 
match DNA sequence.  Circles with two dots represent the lone pairs of N(3) of purines and 
O(2) of pyrimidines.  Circles containing an H represent the N(2) hydrogen of G.  Hydrogen 
bonds are illustrated by dotted lines.  (Bottom) Ball-and-stick binding model for the hairpin 
motif with the polyamide bound to its target DNA sequence.  Imidazole and pyrrole are 
shown as fi lled and non-fi lled circles, respectively; β-alanine is shown as a diamond; 
the dimethylaminopropylamide tail is shown as a half-circle with a plus; and the chiral 
diaminobutyric acid turn residue is shown as a semicircle linked to a half-circle with a plus 
connecting the two subunits.
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WWGWCGW-3’, 5’-WWGWGCW-3’, 5’-WWGCGGW-3’, 5’-WWGCCGW-3’, and 5’-
WWGWGGW-3’.  To complete the library, we have synthesized nine hairpin polyamides 
designed to target these remaining sequences and assayed their binding affi nity and 
sequence specifi city by DNase I footprint titration experiments.  In this study, we complete 
the table of polyamide-DNA binding affi nities, indicating each of the 27 general DNA 
sequences and an eight-ring hairpin polyamide that sequence specifi cally binds that 7-bp 
site.  We hope that this centralized source of previously unpublished data proves helpful 
for other research groups currently modulating protein-DNA interfaces with DNA-binding 
small molecules.
2.2.  Results
2.2.1.  Polyamide synthesis.  Nine polyamides 12, 13, 14, 16, 17, 19, 21, 24, and 
27 were synthesized on Boc-β-Ala-PAM resin according to published manual solid-phase 
synthesis protocols.34  After cleavage with 3-dimethylamino-1-propylamine and reverse-
phase HPLC purifi cation, polyamides were characterized by analytical HPLC, UV-
visible spectroscopy, and matrix-assisted laser desorption ionization/time-of-fl ight mass 
spectrometry.
2.2.2.  DNA binding energetics.  Quantitative DNase I footprint titration 
experiments (10 mM Tris-HCl, 10 mM KCl, 10 mM MgCl2, and 5 mM CaCl2, pH 7.0, 
22°C) were performed on the 295 bp, 5’-32P-end-labeled PCR product of plasmids pCFH2, 
pCFH3, pCFH4, pCFH5, pPh2, and pMFST.35  Each of the nine polyamides was assayed 
on a plasmid containing its 7-bp match site according to the pairing rules, as well as three 
formal mismatch binding sites (Table 2.1 and Figure 2.2).  The energetics of polyamide 
binding in the minor groove of DNA can be calculated from the Hill equation isotherms 
following DNase I cleavage and gel separation of the fragments.  The equilibrium association 
constants (Ka) determined in this way provide a quantitative measure of polyamide affi nity 
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pCFH2
5’-TGGATGCTGGTT ATGCATA TGGATGCTGGTT ATGCCTA TGGATGCTGGTT ATGCGTA TGGATGCTGGTT ATGCTTA TGGATGCTAA-3’
3’-ACCTACGACCAA TACGTAT ACCTACGACCAA TACGGAT ACCTACGACCAA TACGCAT ACCTACGACCAA TACGAAT ACCTACGATT-5’
+ + 17
+ + 14+ + 19
pCFH3
5’-TGGATGCTGGTT ATGCACA TGGATGCTGGTT ATGCCCA TGGATGCTGGTT ATGCGCA TGGATGCTGGTT ATGCTCA TGGATGCTAA-3’
3’-ACCTACGACCAA TACGTGT ACCTACGACCAA TACGGGT ACCTACGACCAA TACGCGT ACCTACGACCAA TACGAGT ACCTACGATT-5’
+ + 16 + + 16
pPh2
5’-TGGATGCTGGTT ATGCAGT TGGATGCTGGTT ATGCCGT TGGATGCTGGTT ATGCGGT TGGATGCTGGTT ATGCTGT TGGATGCTAA-3’
3’-ACCTACGACCAA TACGTCA ACCTACGACCAA TACGGCA ACCTACGACCAA TACGCCA ACCTACGACCAA TACGACA ACCTACGATT-5’
+ + 24 + + 21
pCFH4
5’-TGGATGCTGGTT ATGAAGT TGGATGCTGGTT ATGACGT TGGATGCTGGTT ATGAGGT TGGATGCTGGTT ATGATGT TGGATGCTAA-3’
3’-ACCTACGACCAA TACTTCA ACCTACGACCAA TACTGCA ACCTACGACCAA TACTCCA ACCTACGACCAA TACTACA ACCTACGATT-5’
32P EcoRI PvuIIA•T C•G G•C T•A
+ + 13
pCFH5
5’-TGGATGCTGGTT ATGAACT TGGATGCTGGTT ATGACCT TGGATGCTGGTT ATGAGCT TGGATGCTGGTT ATGATCT TGGATGCTAA-3’
3’-ACCTACGACCAA TACTTGA ACCTACGACCAA TACTGGA ACCTACGACCAA TACTCGA ACCTACGACCAA TACTAGA ACCTACGATT-5’
+ + 27
pMFST
5’-TACAATCAT TAGTGGT TACAATC ATATGGT CATACAATCAT TAGTCGT TACAATCATTAGCACACACAATCAT-3’
3’-ATGTTAGTA ATCACCA ATGTTAG TATACCA GTATGTTAGTA ATCAGCA ATGTTAGTAATCGTGTGTGTTAGTA-5’
+ + 12
at a given DNA binding site.  Comparing these constants across the four potential binding 
sites allows a relative measure of specifi city for each base pair at the targeted position.
The nine polyamides 12, 13, 14, 16, 17, 19, 21, 24 and 27 bind their respective 7-bp 
match sites with equilibrium association constants that range from Ka = 7×10
8 M-1 to 4×1010 
M-1 (Table 2.1 and Figure 2.3).  The sequence specifi cities (Kmatch/Ksingle bp mismatch) for these 
compounds vary from 4-fold to greater than 100-fold, further validating the pairing rules.
 
Figure 2.2.  Plasmid design for pCFH2, pCFH3, pCFH4, pCFH5, pPh2, and pMFST, 
indicating the designed match and mismatch sites for hairpin polyamides 12, 13, 14, 16, 
17, 19, 21, 24, and 27.  Imidazole and pyrrole are shown as fi lled and non-fi lled circles, 
respectively; β-alanine is shown as a diamond; the dimethylaminopropylamide tail is 
shown as a half-circle with a plus; and the chiral diaminobutyric acid turn residue is shown 
as a semicircle linked to a half-circle with a plus connecting the two subunits.
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Figure 2.3.  Quantitative DNase I footprint titration experiments for 
polyamides 13, 14, 16, 17, 19, 21, 24, and 27 on the 295 bp, 5’-32P-end-
labeled PCR product of plasmids pCFH2, pCFH3, pCFH4, pCFH5, and 
pPh2:  lane 1, intact DNA; lane 2, G reaction; lane 3, A reaction; lane 4, 
DNase standard; lanes 5-15, 10 pM, 30 pM, 100 pM, 300 pM, 1 nM, 3 nM, 
10 nM, 30 nM, 100 nM, 300 nM, 1 μM, respectively.  Binding isotherms 
for the four designed sites are shown below each footprinting gel; θnorm 
values were calculated according to published methods.  A binding model 
for the hairpin motif is shown above each gel with the polyamide bound 
to its target DNA sequence.  Imidazole and pyrrole are shown as fi lled 
and non-fi lled circles, respectively; β-alanine is shown as a diamond; the 
dimethylaminopropylamide tail is shown as a half-circle with a plus; and 
the chiral diaminobutyric acid turn residue is shown as a semicircle linked 
to a half-circle with a plus connecting the two subunits.
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Table 2.1.  Equilibrium association constants Ka (M-1) a
pCFH2 (5’→3’) ATGCATA ATGCCTA ATGCGTA ATGCTTA
pCFH3 (5’→3’) ATGCACA ATGCCCA ATGCGCA ATGCTCA
pPh2 (5’→3’) ATGCAGA ATGCCGA ATGCGGA ATGCTGA
pCFH4 (5’→3’) ATGAAGA ATGACGA ATGAGGA ATGATGA
14 + +
19 + +
16 + +
21 + +
24 + +
17 + +
7.5 (±5.0)×107 3.0 (±1.0)×107 2.1 (±0.2)×109 4.6 (±2.6)×107
< 1×107 7.0 (±2.2)×108 1.4 (±0.5)×107 3.6 (±1.3)×107
7.0 (±1.3)×109 2.5 (±1.3)×108 2.5 (±1.0)×109 9.3 (±2.5)×109
< 3.3×107 < 3.3×107 9.3 (±0.5)×108
< 1×107
< 3.3×107
2.4 (±0.5)×109 1.1 (±0.3)×107 2.2 (±1.4)×107
5.1 (±3.3)×107 1.3 (±0.1)×1010 1.8 (±0.7)×108 2.9 (±1.0)×108
27 + + < 1×107 1.8 (±0.3)×109 9.8 (±1.3)×107 7.1 (±0.6)×107
pCFH5 (5’→3’) ATGAACT ATGACCT ATGAGCT ATGATCT
13 + + 5.3 (±1.4)×108 9.5 (±4.4)×107 2.2 (±0.4)×109 8.2 (±4.1)×107
pMFST (5’→3’) TAGTGGT ATATGGT TAGTCGT
12 4.3 (±0.3)×1010 9.9 (±0.6)×108 6.2 (±0.2)×109+ +
a Ka (M
-1) values reported are the mean values from at least three DNase I footprint titration 
experiments, with the standard deviation given in parentheses.  Assays were performed 
at 22°C in a buffer of 10 mM Tris-HCl, 10 mM KCl, 10 mM MgCl2, and 5 mM CaCl2 
at pH 7.0.  Imidazole and pyrrole are shown as fi lled and non-fi lled circles, respectively; 
β-alanine is shown as a diamond; the dimethylaminopropylamide tail is shown as a half-
circle with a plus; and the chiral diaminobutyric acid turn residue is shown as a semicircle 
linked to a half-circle with a plus connecting the two subunits.
2.2.3.  Table of DNA Binding Affi nities for a Hairpin Polyamide Library.  Having 
determined the binding affi nities for these nine hairpin polyamides, a table of equilibrium 
association constants can be populated for the general sequence 5’-WWGNNNW-3’ (where 
N = W, G, or C) (Table 2.2).  Eight-ring hairpin polyamides can be used to sequence 
specifi cally target all of the 27 general sequences with an equilibrium association constant 
Ka ≥ 1×10
8 M-1.  Each of these 27 compounds shown represents a current best solution for 
its DNA sequence.
25
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
+
+
+ +
+ +
+
+ +
+ +
+
+ +
+
+
+ +
+ +
+ +
+ +
+ +
+ +
+
+ +
+ +
+ +
+ +
+ +
+ +
+
+
+ +
3×109
5×108
4×109
9×109
3×1010
2×109
5×109
3×108
1×1010
1×1010
4×108
4×1010
2×109
2×109
2×109
9×109
1×1010
2×109
7×108
2×108
9×108
2×108
1×108
2×109
9×109
3×109
1×109
WWGWWWW
WWGGWWW
WWGWGWW
WWGWWGW
WWGWWCW
WWGWCWW
WWGCWWW
WWGGGWW
WWGGWGW
WWGGWCW
WWGGCWW
WWGWGGW
WWGWGCW
WWGCGWW
WWGCWGW
WWGCWCW
WWGWCGW
WWGWCCW
WWGCCWW
WWGGGGW
WWGCGGW
WWGGCGW
WWGGGCW
WWGCCGW
WWGGCCW
WWGCGCW
WWGCCCW
Polyamide Ka (M-1)General (5’→3’) Ref
23
42
43
44
23
c
45
46
51
24
47
b
b
b
48
b
b
49
b
c
b
c
c
b
50
37
b
Sequence context
5’-TAGTATT-3’
5’-CTGGTTA-3’
5’-TAGTGAA-3’
5’-TAGTAGT-3’
5’-TAGTACT-3’
5’-GAGTCTA-3’
5’-ATGCAAA-3’
5’-AAGGGAA-3’
5’-TAGGTGT-3’
5’-ATGGTCA-3’
5’-AAGGCAT-3’
5’-TAGTGGT-3’
5’-ATGAGCT-3’
5’-ATGCGTA-3’
5’-TAGCAGT-3’
5’-ATGCTCA-3’
5’-ATGACGT-3’
5’-TAGACCA-3’
5’-ATGCCTA-3’
5’-GAGGGGT-3’
5’-ATGCGGT-3’
5’-CAGGCGT-3’
5’-CTGGGCA-3’
5’-ATGCCGT-3’
5’-ATGGCCA-3’
5’-ATGCGCA-3’
5’-ATGCCCA-3’
Table 2.2.  Equilibrium association constants Ka (M-1) a
a Ka (M
-1) values reported are the mean values from at least three DNase I footprint titration 
experiments.  Assays were performed at 22°C in a buffer of 10 mM Tris-HCl, 10 mM KCl, 10 
mM MgCl2, and 5 mM CaCl2 at pH 7.0.  Imidazole and pyrrole are shown as fi lled and non-
fi lled circles, respectively; β-alanine is shown as a diamond; the dimethylaminopropylamide 
tail is shown as a half-circle with a plus; the achiral γ-aminobutyric acid turn residue is 
shown as a semicircle connecting the two subunits; and the chiral diaminobutyric acid 
turn residue is shown as a semicircle linked to a half-circle with a plus connecting the two 
subunits; b Table 2.1; c Figure 2.4
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2.3.  Discussion
The microstructure of DNA is sequence dependent, and each hairpin polyamide 
acts as a microcaliper for the shape (width, depth) of the minor groove of DNA.  Hence, it 
is not surprising that the energetics of hairpin binding for match sequences varies over two 
orders of magnitude (108-1010 M-1) and is DNA sequence dependent.  We would assume for 
transcriptional factor inhibition experiments one would prefer the highest affi nity binding 
molecules.  In the hairpin binding motif, β-alanine has been found to be a good structural 
replacement for Py, as the β/Im pair is specifi c for C•G and β/Py and β/β both code for 
A,T.36,37  Furthermore, when β replaces Py adjacent to Im, binding is generally improved, 
as this fl exible residue is believed to allow the amino acid pairings to reset their register 
with the DNA base pairs.37,38  A key example of the use of β to replace Py can be seen in 
polyamide 26.  ImPyImPy-γ-ImPyImPy-β-Dp binds its target sequence 5’-ATGCGCA-
3’ with a binding affi nity of 3×107 M-1.  Replacement of the internal Py residues with β 
residues yields the polyamide Im-β-ImPy-γ-Im-β-ImPy-β-Dp, which has a binding affi nity 
of 3×109 M-1, a 100-fold improvement.37
The chiral substitution of the γ-aminobutyric acid turn residue has been shown to 
improve binding affi nity and sequence specifi city.32  For polyamides 14, 16, 19, and 24, 
the chiral diaminobutyric acid turn residue increases equilibrium association constants for 
these polyamides by 7- to 50-fold over their achiral variants (Table 2.3).  In the example 
of polyamide 21, the achiral pyrrole-imidazole compound (ImPyImIm-γ-PyPyImPy-
β-Dp) binds its target sequence with an affi nity of less than 1×107 M-1, while the chiral 
version with β-alanine (Im-β-ImIm-(R)H2Nγ-PyPyImPy-β-Dp) exhibits greater than 90-
fold enhancement, binding with an affi nity of 9×108 M-1.  The combination of β-alanine 
substitution when appropriate and incorporation of the chiral turn can yield signifi cantly 
improved DNA binding.
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1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+
+ +
-
-
4×109
9×109
-
2×109
5×109
-
1×1010
-
-
4×1010
2×109
2×109
2×109
9×109
1×1010
-
7×108
2×108
9×108
2×108
1×108
2×109
-
3×109
1×109
WWGWWWW
WWGGWWW
WWGWGWW
WWGWWGW
WWGWWCW
WWGWCWW
WWGCWWW
WWGGGWW
WWGGWGW
WWGGWCW
WWGGCWW
WWGWGGW
WWGWGCW
WWGCGWW
WWGCWGW
WWGCWCW
WWGWCGW
WWGWCCW
WWGCCWW
WWGGGGW
WWGCGGW
WWGGCGW
WWGGGCW
WWGCCGW
WWGGCCW
WWGCGCW
WWGCCCW
Chiral/β Ka (M-1)General (5’→3’) Ref
-
-
43
44
-
c
45
-
51
-
-
b
b
b
48
b
b
-
b
c
b
c
c
b
-
37
b
Sequence context
-
-
5’-TAGTGAA-3’
5’-TAGTAGT-3’
-
5’-GAGTCTA-3’
5’-ATGCAAA-3’
-
5’-TAGGTGT-3’
-
-
5’-TAGTGGT-3’
5’-ATGAGCT-3’
5’-ATGCGTA-3’
5’-TAGCAGT-3’
5’-ATGCTCA-3’
5’-ATGACGT-3’
-
5’-ATGCCTA-3’
5’-GAGGGGT-3’
5’-ATGCGGT-3’
5’-CAGGCGT-3’
5’-CTGGGCA-3’
5’-ATGCCGT-3’
-
5’-ATGCGCA-3’
5’-ATGCCCA-3’
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
Achiral
3×109
5×108
7×108
-
3×1010
-
-
3×108
-
1×1010
4×108
-
-
9×107
-
6×108
-
2×109
1×108
2×107
< 1×107
-
-
4×107
9×109
3×107
< 2×108
Ka (M-1) Ref
23
42
43
-
23
-
-
46
-
24
47
-
-
d
-
d
-
49
d
50
d
-
-
d
50
50
45
Sequence context
5’-TAGTATT-3’
5’-CTGGTTA-3’
5’-TAGTGAA-3’
-
5’-TAGTACT-3’
-
-
5’-AAGGGAA-3’
-
5’-ATGGTCA-3’
5’-AAGGCAT-3’
-
-
5’-ATGCGTA-3’
-
5’-ATGCACA-3’
-
5’-TAGACCA-3’
5’-ATGCCTA-3’
5’-ATGGGGA-3’
5’-ATGCGGT-3’
-
-
5’-ATGCCGT-3’
5’-ATGGCCA-3’
5’-ATGCGCA-3’
5’-TAGCCCA-3’
Table 2.3.  Equilibrium association constants Ka (M-1) a
a Ka (M
-1) values reported are the mean values from at least three DNase I footprint titration 
experiments.  Assays were performed at 22°C in a buffer of 10 mM Tris-HCl, 10 mM KCl, 10 
mM MgCl2, and 5 mM CaCl2 at pH 7.0.  Imidazole and pyrrole are shown as fi lled and non-
fi lled circles, respectively; β-alanine is shown as a diamond; the dimethylaminopropylamide 
tail is shown as a half-circle with a plus; the achiral γ-aminobutyric acid turn residue is 
shown as a semicircle connecting the two subunits; and the chiral diaminobutyric acid 
turn residue is shown as a semicircle linked to a half-circle with a plus connecting the two 
subunits; b This paper, Table 2.1; c This paper, Figure 2.4; d Previously unpublished data
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2.4.  Conclusion
We report here nine new eight-ring hairpin polyamides and assay their DNA-binding 
properties.  These characterizations mark the completion of a 27-member polyamide 
library that covers all 7-bp DNA sequences 5’-WWGNNNW-3’ (N = W, G, or C), where 
each compound binds its respective sequence with Ka ≥ 1×10
8 M-1.  Typical fold change 
for match versus single base-pair mismatch sites is in the range of 4 to 100.  Looking 
forward, one could imagine using a DNA microarray-based approach to interrogate the 
entire sequence-recognition profi le of each member of the 27 hairpin polyamide library on 
every permutation of DNA sites seven base pairs in size.52  We hope that this compilation 
of polyamide-DNA binding affi nities will serve as a resource for ongoing small molecule 
gene regulation projects.
2.5.  Experimental
2.5.1 Materials. (tert-Butoxycarbonyl)-β-alanine-PAM resin (Boc-β-Ala-PAM resin, 
divinylbenzene 1%, 200-400 mesh, 0.81 meq/g loading), Nα-9-fl uorenylmethoxycarbonyl-
Nγ-tert-butoxycarbonyl-D-2,4-diaminobutyric acid (Fmoc-D-Dab(Boc)-OH), and O-
(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafl uorophosphate (HBTU) 
were purchased from Peptides International.  1-Methyl-2-pyrrolidinone (NMP), N,N-
diisopropylethylamine (DIEA), and 3-dimethylamino-1-propylamine (Dp) were purchased 
from Aldrich.  N,N-Dimethylformamide (DMF) was purchased from EMD Biosciences, 
dichloromethane (DCM) was purchased from Fisher Scientifi c, and trifl uoroacetic acid 
(TFA) was purchased from Halocarbon.  Oligonucleotide inserts were synthesized by 
Integrated DNA Technologies.  Bam HI, Hind III, polynucleotide kinase, DNase I, rapid 
DNA ligation kit, PCR core kit, and glycogen were purchased from Roche.  JM109 
competent cells and Wizard Plus Midipreps DNA Purifi cation System were purchased 
from Promega.  pUC19 plasmid DNA, β-mercaptoethanol, bromophenol blue, and xylene 
cyanole were purchased from Sigma.  Calf thymus DNA and ProbeQuant G-50 Micro 
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Figure 2.4.  Quantitative DNase I footprint titration experiments for polyamides 6, 12, 20, 
22, and 23.  A binding model for the hairpin motif is shown above each gel with the polyamide 
bound to its target DNA sequence.  Imidazole and pyrrole are shown as fi lled and non-fi lled 
circles, respectively; β-alanine is shown as a diamond; the dimethylaminopropylamide 
tail is shown as a half-circle with a plus; and the chiral diaminobutyric acid turn residue is 
shown as a semicircle linked to a half-circle with a plus connecting the two subunits.
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Columns were purchased from Amersham Biosciences.  Adenosine 5’-triphosphate [γ-
32P], DL-dithiothreitol, and Tris were purchased from MP Biomedicals.  0.5 M EDTA, 
pH 8.0, phenol:chloroform:isoamyl alcohol (25:24:1 v/v), and formamide were purchased 
from Invitrogen.   Potassium chloride, magnesium chloride, calcium chloride, and sodium 
chloride were purchased from Mallinckrodt.  RNase-free water was purchased from USB. 
8% Gene-PAGE PLUS, 7 M urea, denaturing acrylamide blend was purchased from 
Amresco.  Tris borate EDTA was purchased from National Diagnostics.  All reagents were 
used without further purifi cation.
HPLC analysis was performed on a Beckman Gold system using a Phenomenex 
Gemini 4.6 × 250 mm, 5 μm 100 Å C18 reverse-phase column in 0.1% (w/v) TFA with 
acetonitrile as the eluent.  Preparatory HPLC was carried out on a Beckman Gold system 
using either a Waters Delta-Pak 25 × 100 mm, 15 μm 300 Å C18 PrepPak Cartridge reverse-
phase column or a Varian Dynamax 21.4 × 250 mm Microsorb 8 μm 300 Å C8 reverse-phase 
column in 0.1% (w/v) TFA with acetonitrile as the eluent.  UV spectra were measured on an 
Agilent Technologies 8453 UV-Vis ChemStation spectrophotometer.  Matrix-assisted laser 
desorption ionization/time-of-fl ight mass spectrometry (MALDI-TOF-MS) was carried 
out on an Applied Biosystems Voyager DE-PRO.  Storage phosphor autoradiography was 
performed on a Molecular Dynamics Typhoon 8600 phosphorimager.  18MΩ water was 
obtained from an AquaMAX Ultra water purifi cation system, and all buffers were 0.2 μm 
fi ltered.
2.5.2.  Polyamide synthesis.  Polyamides were synthesized using pre-loaded Boc-
β-Ala-PAM resin (50 mg, 0.81 meq/g) according to published manual solid-phase synthesis 
protocols.34  The resin was cleaved with neat 3-dimethylamino-1-propylamine (1 mL) at 
37°C with agitation for 16 h.  Products were purifi ed by preparatory reverse-phase HPLC 
and characterized by analytical HPLC, UV-visible spectroscopy, and MALDI-TOF mass 
spectrometry.
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2.5.2.1. Im-β-ImIm-(R)H2Nγ-PyPyPyPy-β-Dp (12). Polyamide 12 was isolated 
upon lyophilization of the appropriate fractions as a white powder (0.1 mg, 0.1% recovery). 
UV (H2O) λmax = 309 nm; MALDI-TOF-MS (monoisotopic) m/z 1187.86 (1187.57 calcd 
for [M + H]+ C54H71N22O10
+).
2.5.2.2. ImPyImPy-(R)H2Nγ-ImPyPyPy-β-Dp (13).  Polyamide 13 was isolated 
upon lyophilization of the appropriate fractions as a white powder (0.1 mg, 0.1% recovery). 
UV (H2O) λmax = 314 nm; MALDI-TOF-MS (monoisotopic) m/z 1238.59 (1238.58 calcd 
for [M + H]+ C57H72N23O10
+).
2.5.2.3. ImPyImPy-(R)H2Nγ-PyPyImPy-β-Dp (14).  Polyamide 14 was isolated 
upon lyophilization of the appropriate fractions as a white powder (0.1 mg, 0.1% recovery). 
UV (H2O) λmax = 315 nm; MALDI-TOF-MS (monoisotopic) m/z 1238.58 (1238.58 calcd 
for [M + H]+ C57H72N23O10
+).
2.5.2.4. ImPyPyPy-(R)H2Nγ-ImPyImPy-β-Dp (16).  Polyamide 16 was isolated 
upon lyophilization of the appropriate fractions as a white powder (0.4 mg, 1.5% recovery). 
UV (H2O) λmax = 315 nm; MALDI-TOF-MS (monoisotopic) m/z 1238.49 (1238.58 calcd 
for [M + H]+ C57H72N23O10
+).
2.5.2.5. ImPyPyIm-(R)H2Nγ-PyImPyPy-β-Dp (17). Polyamide 17 was isolated 
upon lyophilization of the appropriate fractions as a white powder (1.8 mg, 7.1% recovery). 
UV (H2O) λmax = 316 nm; MALDI-TOF-MS (monoisotopic) m/z 1238.63 (1238.58 calcd 
for [M + H]+ C57H72N23O10
+).
2.5.2.6. ImPyPyPy-(R)H2Nγ-PyImImPy-β-Dp (19). Polyamide 19 was isolated 
upon lyophilization of the appropriate fractions as a white powder (0.9 mg, 3.8% recovery). 
UV (H2O) λmax = 312 nm; MALDI-TOF-MS (monoisotopic) m/z 1238.63 (1238.58 calcd 
for [M + H]+ C57H72N23O10
+).
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2.5.2.7. Im-β-ImIm-(R)H2Nγ-PyPyImPy-β-Dp (21). Polyamide 21 was isolated 
upon lyophilization of the appropriate fractions as a white powder (0.3 mg, 0.2% recovery). 
UV (H2O) λmax = 309 nm; MALDI-TOF-MS (monoisotopic) m/z 1188.67 (1188.57 calcd 
for [M + H]+ C53H70N23O10
+).
2.5.2.8. ImPyPyIm-(R)H2Nγ-PyImImPy-β-Dp (24). Polyamide 24 was isolated 
upon lyophilization of the appropriate fractions as a white powder (1.9 mg, 7.5% recovery). 
UV (H2O) λmax = 310 nm; MALDI-TOF-MS (monoisotopic) m/z 1239.67 (1239.58 calcd 
for [M + H]+ C56H71N24O10
+).
2.5.2.9. ImPyPyPy-(R)H2Nγ-ImImImPy-β-Dp (27). Polyamide 27 was isolated 
upon lyophilization of the appropriate fractions as a white powder (0.1 mg, 0.1% recovery). 
UV (H2O) λmax = 310 nm; MALDI-TOF-MS (monoisotopic) m/z 1239.60 (1239.58 calcd 
for [M + H]+ C56H71N24O10
+).
2.5.3.  DNase I footprinting experiments.  Plasmids pCFH2, pCFH3, pCFH4, 
pCFH5, pPh2, and pMFST were constructed according to standard protocols for DNA 
manipulation.39  PCR products (295 bp, 5’-32P-end-labeled) were isolated and DNase I 
footprint titrations were performed according to standard protocols.35  Chemical sequencing 
reactions were performed according to published methods.40,41
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Chapter 3
Quantitating the Concentration of Py-Im Polyamide-Fluorescein
Conjugates in Live Cells
The text of this chapter was taken in part from a manuscript co-authored with Peter B. 
Dervan (Caltech).
(Hsu, C. F., Dervan, P. B. Bioorg. Med. Chem. Lett. (2008) article in press,
doi:10.1016/j.bmcl.2008.05.063)
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Abstract
Quantitative fl uorescence-based methods have been developed to determine the 
nuclear concentration of polyamide-fl uorescein conjugates in cell culture.  Confocal laser 
scanning microscopy and fl ow cytometry techniques are utilized to plot calibration curves, 
from which the nuclear concentration can be interpolated.  Upon treatment with polyamide, 
the concentration in the nucleus of live HeLa cells is calculated to be between 0.1-0.5 μM, 
which is signifi cantly lower than the 2 μM dosage concentration.  In contrast, the observed 
nuclear concentration in U251 cells is closer to the dosage concentration, indicating a cell 
line-specifi c increase in uptake for this class of compounds.  Although confocal microscopy 
and fl ow cytometry generate disparate values, taken together these experiments suggest 
that the polyamide concentration inside the cell nucleus is lower than it is outside the cell.
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3.1.  Introduction
Hairpin pyrrole-imidazole polyamides are synthetic ligands that target predetermined 
DNA sequences with affi nities comparable to those of naturally occurring DNA-binding 
proteins.1,2  These cell-permeable small molecules have been shown to localize to 
the nucleus of living cells3-7 and regulate endogenous gene expression.8-12  Polyamides 
selectively bind in the minor groove of DNA according to a set of “pairing rules,” where 
each heterocyclic ring pair targets a specifi c Watson-Crick base pair.1,2  The antiparallel 
pairing of N-methylpyrrole (Py) and N-methylimidazole (Im) aromatic rings targets the 
C•G base pair, while Im/Py discriminates G•C.13-16  The Py/Py pair recognizes A•T and 
T•A, while chlorothiophene can be paired with Py to distinguish T•A at the N-terminus.17
Polyamide-small molecule conjugates have been utilized in a number of 
applications.18-21  In particular, with laser microscopy it is possible to visualize the uptake 
of polyamide-fl uorophore conjugates as they traffi c unaided to the nucleus of live cells.3-
6  This advance has helped to usher in an era of gene regulation.8-11  Traditionally, we 
have used a qualitative scoring system to rate the extent of nuclear localization in cell 
culture.5,6  Upon incubation with polyamide and direct imaging of cells, the fl uorescence 
intensity in the nucleus is compared to that in the medium.  Positive scores are assigned 
when the nuclear staining exceeds that of the medium.  The degree of nuclear localization 
varies across polyamide design, fl uorophore selection, and cell type.3-6  Quantitating the 
polyamide concentration within the cell nucleus would be an improvement over the current 
“yes/no” rating, thus creating a digital readout of cellular uptake.
Our quantitative approach utilizes two different fl uorescent imaging technologies. 
First, with confocal laser scanning microscopy, we can compare images of cells to images 
of calibration standards containing known polyamide concentrations, then interpolate to 
determine the nuclear concentration in the cell.  Next, we can corroborate this value with 
additional evidence from fl ow cytometry.  Here, the fl uorescence of live cells is compared 
to a calibration curve built using beads functionalized with known amounts of fl uorophore, 
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yielding the interpolated number of fl uorophores per cell.  Taken together, these values 
provide a numerical range that is not apparent from previous qualitative experiments.  In this 
study, we investigate the nuclear concentration of two polyamide-fl uorescein conjugates in 
two cell lines using confocal laser scanning microscopy and fl ow cytometry.
3.2.  Polyamide synthesis
For these experiments, we wanted to examine polyamide-fl uorescein conjugates that 
traffi c strongly to the nucleus of live cells (Figure 3.1).  Polyamide 1 specifi cally targets the 
DNA sequence 5’-WTWCGW-3’ with an equilibrium association constant of 3.8×109 M-1, 
while polyamide 2 binds 5’-WGGWCW-3’ with an affi nity of 6.3×109 M-1 (Figure 3.2). 
For these molecules synthesized with Boc-β-Ala-PAM resin, the 1,3-diaminopropane (C3) 
linker is used to connect the polyamide and fl uorescein moiety.
Polyamides 1 and 2 show positive nuclear localization in HeLa and U251 cell culture 
by confocal laser scanning microscopy (Figure 3.1).  In each of these images, the nuclear 
staining exceeds that of the medium, and all are qualitatively rated as + +.5,6    Furthermore, 
conjugate 1 binds to the hypoxia response element (HRE) and inhibits vascular endothelial 
growth factor (VEGF) expression in HeLa cells by quantitative RT-PCR, while the mismatch 
control compound 2 does not downregulate gene expression (Figure 3.2).8-10
3.3.  Steady-state fl uorimetry
Fluorescence enhancement is observed when polyamide-fl uorophore conjugates 
bind DNA.22-25  When in solution, the fl uorescence of the conjugate is largely quenched, 
but, upon DNA binding, sequestration of the polyamide in the minor groove restores 
fl uorescence.  The fl uorescence enhancements of polyamides 1 and 2 were 14- and 36-
fold, respectively, as determined by steady-state fl uorimetry (Figure 3.3).  The fl uorescent 
nuclei observed in confocal microscopy images appear much brighter than the background 
medium.  Does this mean that the nuclear polyamide concentration is very high, or does the 
fl uorescence enhancement dominate?
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Figure 3.1.  (A) Structures of polyamide-fl uorescein conjugates 1 and 2.  Imidazole and 
pyrrole are shown as fi lled and non-fi lled circles, respectively; chlorothiophene is shown 
as a square; β-alanine is shown as a diamond; the 1,3-diaminopropane linker is shown as 
“C3”; and the chiral diaminobutyric acid turn residue is shown as a semicircle connecting 
the two subunits linked to a half-circle with a plus.  (B) Confocal laser scanning microscopy 
images of polyamide-fl uorescein conjugates 1 and 2 in HeLa and U251 cell lines.  Cells 
were incubated with 2 μM polyamide for 12-14 hours at 37°C in a 5% CO2 atmosphere.
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Figure 3.2.  (A) Quantitative DNase I footprint titration experiments for polyamides 1 and 
2; lane 1, intact DNA; lane 2, G reaction; lane 3, A reaction; lane 4, DNase standard; lanes 
5-15, polyamide concentrations.  Binding isotherms are shown below each footprinting gel; 
θnorm values were calculated according to published methods.28  (B) Quantitative RT-PCR 
data for 1 and 2 in HeLa cells induced with deferoxamine (DFO).8-10  The fi nal concentration 
of compound 1 was 0.2 μM or 1 μM.  The fi nal concentration of compound 2 was 1 μM.
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Figure 3.3.  (A) Overlaid fl uorescence emission spectra for polyamides 1 (top) and 2 
(bottom).  The polyamide concentration is 2 μM.  Calf thymus DNA concentrations are 
0, 0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 1, 2, 4, 6, 8, 10, 20, 40, 60, 80, 100, 200, 400, 600, 
800, and 1000 μM bp.  (B) Confocal laser scanning microscopy images of polyamide-
fl uorescein conjugate 1 in HeLa cells.  Cells were incubated with 2 μM polyamide for 
12-14 hours at 37°C in a 5% CO2 atmosphere.  500 μM bp calf thymus DNA was added 1 
hour prior to imaging.
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In order to control for this effect, calf thymus DNA was added to the medium prior 
to imaging.  This allows the direct comparison of polyamide concentration inside the cell 
nucleus and outside the cell by increasing the fl uorescence of both simultaneously.  This 
experiment generates a picture of dark cells in a background of fl uorescently enhanced 
polyamide solution (Figure 3.3).  Overlay of the fl uorescence and bright-fi eld images 
indicates that the fl uorescence in the cell nucleus is signifi cantly lower than that of the 
medium.  The image of the “dark” nucleus implies that the nuclear concentration is lower 
than the dosage concentration.
3.4.  Confocal microscopy
For the fi rst quantitative approach, the fl uorescence of cells was compared to the 
fl uorescence of calibration standards containing known polyamide concentrations, using 
images taken with a confocal laser scanning microscope.  After building a linear calibration 
curve with the known concentration values, the nuclear concentration in the cell was 
determined by interpolation (Figure 3.4 and Figure 3.5).  Cells were incubated with 2 μM 
polyamide for 12-14 hours in a 5% CO2 atmosphere at 37°C and imaged directly.  Calibration 
standards contained both polyamide and 500 μM bp calf thymus DNA.  To investigate 
nuclear concentration, calf thymus DNA was included in the calibration standards to ensure 
that the fl uorescence was turned “on.”  For these experiments, the concentration of calf 
thymus DNA (500 μM bp) is lower than the estimated DNA concentration in the nucleus (5 
mM bp).  Attempts to increase the concentration to the low mM bp range were limited by 
DNA solubility in medium.  Similar experiments in TKMC buffer resulted in fl uorescence 
quenching at the highest DNA concentrations.  The actual DNA bp concentration in the 
nucleus could produce increased fl uorescence enhancement and might bring the calculated 
polyamide concentration closer to the values observed in fl ow cytometry experiments.  In 
addition, these experiments were performed on cells with mixed cell cycles, i.e., these 
cells were not grown in synchronized culture.  A minimum of three images were taken per 
condition, with at least ten cells from each image used for analysis.
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Figure 3.5.  Confocal laser scanning microscopy images of calibration standards.
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Table 3.1.  Calculated nuclear concentration from confocal microscopya
The experiments in HeLa cells indicated that the concentration in the cell nucleus 
was 0.5 μM and 0.3 μM for polyamides 1 and 2, respectively (Table 3.1).  These values were 
signifi cantly lower than the 2 μM dosage concentration, which was surprising given that the 
fl uorescence images show the cell nucleus lighting up brightly against a dark background 
of cytoplasm and medium.  The fl uorescence signal from the nucleus exceeds the external 
signal even though the nuclear concentration is lower than the external concentration, as a 
result of fl uorescence enhancement upon binding DNA.
When U251 cells were treated with 2 μM of polyamides 1 and 2, the interpolated 
nuclear concentration values were 1.6 μM and 1.5 μM, respectively.  This observation 
suggests that the nuclear concentration is dependent on cell line, just as it varies for each 
polyamide.  The quantitative approach indicates that U251 cells are more permissive than 
HeLa cells with respect to uptake of this type of molecule.
Polyamide Cell line 2 μM
1
2
1
2
HeLa
HeLa
U251
U251
0.5 (±0.1)
0.3 (±0.1)
1.6 (±0.1)
1.5 (±0.3)
a  Calculated nuclear concentration values reported in μM; column headings indicate dosage 
concentration
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3.5.  Flow cytometry
The fl uorescence of polyamide-containing cells was compared to fl uorescent beads 
in the fl ow cytometer, and interpolation of the linear calibration curve produces the number 
of fl uorophores per cell (Figure 3.6).  Dividing this value by the volume of the nucleus 
yields the calculated nuclear concentration.  Based on confocal microscopy images of HeLa 
and U251 cells, the cell nucleus was modeled as a cylinder with radius 10 μm and height 5 
μm to give a calculated nuclear volume of 1×10-12 L.  As above, cells were incubated with 
polyamide for 12-14 hours in a 5% CO2 atmosphere at 37°C.  After washing, fl uorescence 
was measured by analyzing 10,000 cells in the fl ow cytometer.  Under identical instrument 
settings, SPHERO Rainbow Calibration Particles were analyzed in the fl uorescein fi lter 
set.  The functionalized particles contain eight different amounts of fl uorophore per bead 
and are designed to produce eight separate peaks.  Due to the high fl uorescence levels of 
the cells, only the fi ve highest fl uorophore peaks were resolved within the fl uorescence 
range and used for constructing the linear calibration curve.  The fl uorescence intensity 
of each peak is correlated with a known amount of fl uorophore in solution, although the 
quantum yield of a fl uorophore can change upon binding.26  For analysis, 10,000 events 
were used in fl ow cytometry experiments and calibrations.
For fl ow cytometry experiments, cells were dosed with three different polyamide 
concentrations of 0.4 μM, 2 μM, and 10 μM.  In HeLa cells, the calculated nuclear 
concentrations for compound 1 were 0.02 μM, 0.09 μM, and 0.20 μM (Table 3.2).  While 
the concentration values increase with dosage, each 5-fold increase in dosage does not 
produce a proportional increase in nuclear concentration, and this plateau effect is more 
pronounced at higher dosage concentrations.  In addition, these values were lower than 
those observed in confocal microscopy experiments.  For the same dosage concentration 
of 2 μM, the calculated concentration from fl ow cytometry was 0.09 μM, which is 5-fold 
lower than the interpolated concentration from confocal microscopy (0.5 μM).  The results 
from experiments with compound 2 in HeLa cells are calculated nuclear concentrations of 
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Figure 3.6.  (A) Flow cytometry experiment with calibration particles.  (B) Sample 
calibration curve for fl ow cytometry.  R-squared value is 0.9944.  (C) Flow cytometry 
experiments with HeLa cells incubated with 0 μM (top left), 0.4 μM (top right), 2 μM 
(bottom left), and 10 μM (bottom right) polyamide.
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0.04 μM, 0.14 μM, and 0.35 μM, indicating that uptake is polyamide core-dependent.
When U251 cells were treated with compound 1, the calculated nuclear concentration 
values were 0.09 μM, 0.34 μM, and 0.84 μM.  The relatively high nuclear concentrations 
support the observation that U251 cells are more permissive than HeLa cells, as seen in the 
above confocal microscopy experiments. 
3.6.  Comparison of methods
For each polyamide and cell line explored here, the confocal microscopy method 
produces a higher calculated nuclear concentration value than the fl ow cytometry method. 
For instance, at the 2 μM dosage level in HeLa cells, the polyamides exhibit 0.3-0.5 
μM nuclear concentration by confocal microscopy, as compared to 0.09-0.14 μM by 
fl ow cytometry.  However, both methods support the observation that U251 cells allow 
increased uptake of polyamide-fl uorescein conjugates relative to HeLa cells.  Overall, the 
calculations suggest that the concentration in the nucleus is much lower than that in the 
external medium.  This is the opposite of what one might expect upon seeing brightly 
fl uorescent cell nuclei with a dark background.
Table 3.2.  Calculated cellular concentration from fl ow cytometrya
a  Calculated cellular concentration values reported in μM; column headings indicate dosage 
concentration
Polyamide Cell line 2 μM
1
2
1
2
HeLa
HeLa
U251
U251
0.09 (±0.03)
0.14 (±0.05)
0.34 (±0.23)
0.14 (±0.06)
0.4 μM
0.02 (±0.01)
0.04 (±0.02)
0.09 (±0.04)
0.04 (±0.02)
10 μM
0.20 (±0.06)
0.35 (±0.08)
0.84 (±0.41)
0.34 (±0.17)
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Both of the techniques explored here have strengths and limitations.  Confocal 
microscopy allows data analysis from direct images of cell culture, requiring no further cell 
processing steps.  This method also uses the same compound for calibration and imaging, as 
opposed to a generic fl uorophore.  On the other hand, fl ow cytometry lends itself well to the 
quantitative nature of this study and benefi ts from large sample sizes.  However, the nuclear 
volume is not known with certainty, and the fl ow cytometer measures the fl uorescence of 
the entire cell, not just the nucleus.  Also, the calibration does not take into account the 
fl uorescence enhancement effect; therefore, the calculated nuclear concentration from fl ow 
cytometry represents an upper bound for this value.  
In this study, we elaborate methods for quantitating the concentration of polyamide-
fl uorescein conjugates in live cells, incorporating data gathered from confocal microscopy 
and fl ow cytometry techniques.  When cultured HeLa cells are treated with 2 μM 
polyamide, the calculated nuclear concentration is between 0.09-0.5 μM, suggesting that 
the intracellular concentration is 4- to 25-fold lower than the external concentration.  As 
observed in previous studies, cellular uptake is cell-line dependent.3,5,6  Although qualitative 
images in HeLa and U251 cell lines both receive the same positive rating, it appears that 
the nuclear concentration in U251 cells is actually several-fold higher than in HeLa cells.
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3.7.  Experimental
3.7.1  Polyamide synthesis.  Polyamides were synthesized with Boc-β-Ala-
PAM resin (Peptides International) according to published manual solid-phase synthesis 
protocols.27  The protected FmocHNγ-turn amine was deprotected with 20% piperidine in 
DMF and reprotected as the Boc derivative with a solution of Boc2O (Fluka) and DIEA 
in DMF.  The Boc-protected resin was cleaved with 1 mL of 1,3-diaminopropane at 37°C 
with agitation for 16 h.  Products were purifi ed by preparatory reverse-phase HPLC on 
a Beckman Gold system using either a Waters Delta-Pak 25×100 mm, 15 μm 300 Å C18 
PrepPak Cartridge reverse-phase column or a Varian Dynamax 21.4×250 mm Microsorb 
8 μm 300 Å C8 reverse-phase column in 0.1% (w/v) TFA with acetonitrile as the eluent. 
The appropriate fractions were lyophilized after characterization by analytical HPLC, 
UV-visible spectroscopy, and MALDI-TOF or ESI mass spectrometry.  Conjugates were 
formed by reacting fl uorescein-5-isothiocyanate (FITC, Invitrogen) with the polyamide in 
a solution of DIEA (20 equiv) and DMF for 1 h at room temperature.  Conjugates were 
deprotected with neat TFA (Halocarbon) and triethylsilane for 30 min at room temperature 
before purifi cation by preparatory reverse-phase HPLC.  Lyophilization of the appropriate 
fractions yielded the polyamide conjugates 1 and 2, which were characterized as described 
above.  Extinction coeffi cients were calculated according to standard protocols.28  Chemicals 
not otherwise specifi ed were from Aldrich.
CtPyPyIm-(R)H2Nγ-PyImPyPy-β-C3-FITC (1).  UV-vis (H2O) λmax 310, 444 nm; 
ESI-MS m/z 1633.6 (C76H74ClN22O15S2
– calculated [M-H]– 1633.48)
ImImPyPy-(R)H2Nγ-ImPyPyPy-β-C3-FITC (2).  UV-vis (H2O) λmax 312, 444 nm; 
ESI-MS m/z 1597.5 (C76H77N24O15S
– calculated [M-H]– 1597.57)
3.7.2.  Steady-state fl uorimetry.  For steady-state fl uorimetry experiments, 
titration samples were prepared with sonicated calf thymus DNA (GE Healthcare) as serial 
dilutions with supplemented medium.  Addition of 3 μL of the 100 μM polyamide solution 
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to each dilution yielded a fi nal polyamide concentration of 2 μM.  Fluorescence spectra 
were measured with a Jobin Yvon/SPEX Fluorolog spectrofl uorimeter (Model FL3-11) 
equipped with a Hamamatsu R928 PMT.  Samples were excited at 490 nm using 2 nm 
emission and excitation slits.  Fluorescence was measured from 500 nm to 650 nm at room 
temperature.
3.7.3.  Cell culture.  For cell culture experiments, human cancer cell lines HeLa 
and U251 were cultured in a 5% CO2 atmosphere at 37°C in supplemented DMEM (HeLa, 
GIBCO) or RPMI medium 1640 (U251, GIBCO).5,6  All media were supplemented with 
10% fetal bovine serum (HeLa, Omega Scientifi c) or 5% fetal bovine serum (U251, 
Omega Scientifi c) and 1% penicillin/streptomycin solution (Mediatech).  HeLa cells were 
purchased from ATCC.  U251 cells were received as a gift from Dr. Giovanni Melillo of 
the National Cancer Institute.29  Quantitative RT-PCR experiments were performed using 
HeLa cells according to published protocols.8,9
3.7.4.  Confocal microscopy.  For confocal microscopy experiments, cell lines 
were trypsinized (Mediatech) for 5 min at 37°C, centrifuged for 10 min at 4°C at 100×g, 
and resuspended in fresh medium to a concentration of 1.33×105 cells/mL.5,6  Incubations 
were performed by adding 150 μL of cells into culture dishes equipped with glass bottoms 
for direct imaging (MatTek).  Cells were grown in the glass-bottom dishes for 24 h.  The 
medium was then removed and replaced with 147 μL of fresh medium, followed by addition 
of 3 μL of the 100 μM polyamide solution for a fi nal polyamide concentration of 2 μM. 
Cells were incubated in a 5% CO2 atmosphere at 37°C for 12-14 h.  Imaging was performed 
with a 40× oil-immersion objective lens on a Zeiss LSM 5 Pascal inverted laser scanning 
microscope.  Polyamide-fl uorescein conjugate fl uorescence and visible-light images were 
obtained using standard fi lter sets for fl uorescein.5,6  12-bit images were analyzed using 
Zeiss LSM and ImageJ software.  Calibration standards were prepared from the 100 μM 
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polyamide solution as serial dilutions with fresh medium and were directly imaged in 
glass-bottom dishes in a volume of 150 μL.  Sonicated calf thymus DNA solution (GE 
Healthcare) was added to appropriate calibration standards for a fi nal DNA concentration 
of 500 μM bp.
3.7.5.  Flow cytometry.  For fl ow cytometry experiments, cell lines were trypsinized 
(Mediatech) for 5 min at 37°C, centrifuged for 10 min at 4°C at 100×g, and resuspended 
in fresh medium to a concentration of 1.33×105 cells/mL.  Incubations were performed 
by adding 3 mL of cells into 6-well culture plates (BD Falcon).  Cells were grown in the 
culture plates for 24 h.  The medium was then removed and replaced with fresh medium, 
followed by addition of the appropriate volume of the 100 μM polyamide solution for a 
fi nal polyamide concentration of 0, 0.4, 2, or 10 μM in a fi nal volume of 3 mL.  Cells were 
incubated in a 5% CO2 atmosphere at 37°C for 12-14 h.  Following incubation, cells were 
trypsinized for 5 min at 37°C, centrifuged for 10 min at 4°C at 100×g, and resuspended 
in HBSS solution (no Mg2+, no Ca2+, no phenol red, 2.5 mg/mL BSA fraction V, 10 mM 
HEPES, pH 7.0-7.2) (Sigma).  Cell viability was checked with trypan blue stain, and 
>95% appeared to be viable.  Cells were centrifuged again for 10 min at 4°C at 100×g and 
resuspended in the above HBSS solution to a concentration of 5×105 cells/mL.  The cell 
suspension was pipetted through a cell strainer (BD Falcon) into a 5 mL polystyrene round-
bottom tube (BD Falcon).  Samples were analyzed using a BD FACSCalibur System fl ow 
cytometer.  SPHERO Rainbow Calibration Particles (Spherotech) were used as calibration 
standards.
3.7.6.  Quantitative DNase I footprinting.  For quantitative DNase I 
footprint titration experiments, plasmid pCFH6 was constructed according to 
standard protocols for DNA manipulation.30  The two 87-mer oligonucleotides 5’-
GATCGTGTAATCAAATGGTCATAGCTGTGTAATCATATGGTCATAGCTGT
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GTAATCACATGGTCATAGCTGTGTAATCAGATGGTCATAGC-3’ and 5’-
AGCTGCTATGACCATCTGATTACACAGCTATGACCATGTGATTACACAGC
TATGACCATATGATTACACAGCTATGACCATTTGATTACAC-3’ (Integrated 
DNA Technologies) were annealed and ligated into the BamHI/HindIII (Roche) restriction 
fragment of pUC19 (Sigma).  DNA sequencing of the constructed plasmid was performed 
at the Sequence Analysis Facility at the California Institute of Technology.  The forward 
primer 5’-AATTCGAGCTCGGTACCCGGG-3’ was 32P-labeled at the 5’-end.  The reverse 
primer 5’-CTGGCACGACAGGTTTCCCGAC-3’ was used to amplify plasmid pCFH6 as 
previously described.28  pGL-VEGF-Luc was 5’-end-labeled and amplifi ed as previously 
described.8,9  PCR products (5’-end-labeled, 291 bp for pCFH6, 197 bp for pGL-VEGF-
Luc) were isolated according to standard protocols.28  Quantitative DNase I footprint 
titration experiments were performed on the 5’-32P-end-labeled PCR products of plasmids 
pGL-VEGF-Luc and pCFH6 with polyamides 1 and 2, respectively, according to standard 
protocols.28  Radiolabeled DNA was equilibrated with polyamide solutions for 14-16 h at 
22°C in a buffer of 10 mM Tris-HCl, 10 mM KCl, 10 mM MgCl2, and 5 mM CaCl2 at pH 
7.0 prior to DNase I cleavage.  Chemical sequencing reactions were performed according 
to published methods.31,32  
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Chapter 4A
Effects of Tail Linkages on the Sequence-Specifi c
Recognition of DNA by Hairpin Polyamide Conjugates
This project was done in collaboration with James Puckett (Dervan group, Caltech).
James Puckett synthesized polyamides 6-10 and prepared plasmid pJWP6.
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Abstract
Hairpin pyrrole-imidazole polyamides are synthetic ligands that bind the minor 
groove of DNA at subnanomolar concentrations with programmable sequence specifi city. 
While the empirically derived “pairing rules” have been well characterized for unlinked 
polyamide cores, far less is known about the binding affi nity and sequence specifi city 
of hairpin polyamide conjugates, which are now commonly used for improved nuclear 
localization in biological experiments.  To further our understanding of C-terminal tail 
linkage effects on sequence specifi city, the equilibrium association constants of fi ve 
hairpin polyamide conjugates ImImPyPy-(R)H2Nγ-ImPyPyPy-β-C3-R1 (β = β-alanine, C3 
= 1,3-diaminopropane linker) were measured by quantitative DNase I footprint titration 
experiments on plasmids containing the eight possible 5’-ANTGGTCA-3’ and 5’-
NATGGTCA-3’ binding sites (N = A, T, C, or G).  In addition, the binding affi nities of fi ve 
hairpin polyamide conjugates ImImPyPy-(R)H2Nγ-ImPyPyPy-(+)-R2 ((+) = 3,3’-diamino-
N-methyldipropylamine linker) were analyzed on the same two plasmids.  For both types 
of compounds, the linker moiety exhibited 3- to 8-fold specifi city for A,T over G,C, and the 
R group showed a similar 2- to 9-fold preference for A,T, with amide linkages conferring 
greater specifi city than thiourea linkages.  These results indicate that linkers and functional 
R groups on the tails of hairpin polyamide conjugates have recognition properties that 
should be considered in the design of these molecules to target DNA binding sites.
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4.1.  Introduction
Aberrant gene expression has been implicated as the cause of many diseases.1,2 
Small molecules that can predictably regulate gene transcription could hold promise in 
human medicine.3  Hairpin pyrrole-imidazole polyamides are synthetic ligands that target 
predetermined DNA sequences with affi nities comparable to those of naturally occurring 
DNA-binding proteins in the nanomolar range.4,5  These cell-permeable small molecules 
have been shown to localize to the nucleus of living cells6-10 and regulate endogenous gene 
expression.11  
Polyamides selectively bind in the minor groove of B-form DNA according to a set of 
“pairing rules,” where each heterocyclic ring pair targets a specifi c Watson-Crick base pair.4,5 
The antiparallel pairing of N-methylpyrrole (Py) and N-methylimidazole (Im) aromatic 
rings targets the C•G base pair (bp), while Im/Py discriminates G•C.12,13  The Py/Py pair 
recognizes A•T and T•A base pairs in the DNA minor groove.14  N-methylhydroxypyrrole 
(Hp) can be paired with Py to distinguish T•A from A•T.15,16  Structural data from NMR and 
X-ray crystallography studies have elucidated these binding preferences.12,14,17,18
A covalent γ-aminobutyric acid (γ) linkage pre-organizes two polyamide subunits 
in the DNA minor groove, prepaying the entropic cost of antiparallel binding.19  Like the 
degenerate Py/Py pair, the γ residue at the hairpin “turn” is specifi c for A,T base pairs.20 
The use of chiral (R)-2,4-diaminobutyric acid to replace γ improves binding affi nity 
and enforces a 5’→3’ N→C binding orientation.21  As with the hairpin turn, a variety of 
different “tails” can be designed.  When polyamides are synthesized on solid phase with 
Boc-β-Ala-PAM resin and cleaved with 3-dimethylamino-1-propylamine (Dp), the fi nal 
compound contains a residual β-Dp tail at the C-terminus.22  Quantitative DNase I footprint 
titration experiments using the six-ring hairpin polyamide ImPyPy-(R)H2Nγ-ImPyPy-
β-Dp have demonstrated that both the β-alanine residue and the Dp tail are W-specifi c 
recognition elements, where W = A or T, at the N-1 position.20  Oxime resin can be used to 
synthesize hairpin polyamides that do not contain β-alanine at the C-terminus and allow 
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rational targeting of more sites.23  Interestingly, polyamide-fl uorophore conjugates without 
β-alanine tend to have better nuclear uptake properties than analogs with β-alanine.9,10
Hairpin polyamide cores can be functionalized at the turn and the tail to form 
polyamide conjugates suitable for a number of different applications.  In particular, 
polyamide-fl uorophore conjugates have been used to assay cellular uptake and nuclear 
localization in live cells using confocal microscopy.6-10  In one notable instance, such a 
compound has been shown to downregulate endogenous gene expression in cell culture.11 
However, there is no systematic data comparing the binding affi nities and specifi cities of 
polyamide conjugates with their parent molecules at the N-2 and N-3 positions relative 
to the Py/Im polyamide core recognition element.  Increased understanding of the effects 
on DNA binding would enable rational polyamide conjugate design in future biological 
studies.
In this study, we examine the effects of substitution at the tail on DNA affi nity, 
specifi city, and cellular uptake (Figure 4.1).  The ImImPyPy-(R)H2Nγ-ImPyPyPy-R polyamide 
core sequence was used in all ten compounds.16  In the fi rst series, fi ve molecules of the type 
ImImPyPy-(R)H2Nγ-ImPyPyPy-β-C3-R1 (β = β-alanine, C3 = 1,3-diaminopropane linker) 
were synthesized using Boc-β-Ala-PAM resin.  Fluorescein and 3-carboxyphenyl were 
conjugated to the polyamide using both thiourea and amide linkages.  In the second series, 
fi ve analogous conjugates of the type ImImPyPy-(R)H2Nγ-ImPyPyPy-(+)-R2 ((+) = 3,3’-
diamino-N-methyldipropylamine linker) were synthesized using oxime resin.  The DNA 
binding energetics of all ten compounds were assayed by DNase I footprinting experiments 
on plasmids containing the eight possible 5’-ANTGGTCA-3’ and 5’-NATGGTCA-3’ 
binding sites (N = A, T, C, or G).
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Figure 4.1.  Structures of polyamide conjugates 1-10.  Imidazole and pyrrole are shown 
as fi lled and non-fi lled circles, respectively; β-alanine is shown as a diamond; the 1,3-
diaminopropane linker is shown as “C3”; the 3,3’-diamino-N-methyldipropylamine linker 
is shown as “(+)”; and the chiral diaminobutyric acid turn residue is shown as a semicircle 
connecting the two subunits linked to a half-circle with a plus.
4.2.  Materials and methods
4.2.1.  Polyamide synthesis
Polyamides were synthesized with Boc-β-Ala-PAM resin (compounds 1-5, 
Peptides International) or oxime resin (compounds 6-10, Novabiochem) according to 
published manual solid-phase synthesis protocols.22,23  The protected FmocHNγ-turn amine 
was deprotected with 20% piperidine in DMF and reprotected as the Boc derivative with a 
solution of Boc2O (Fluka) and DIEA in DMF.  The Boc-protected resin was cleaved with 
1 mL of the appropriate amine (1,3-diaminopropane, compounds 1-4; 3-dimethylamino-
1-propylamine, compound 5; 3,3’-diamino-N-methyldipropylamine, compounds 6-10) at 
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37°C with agitation for 16 h.  Products were purifi ed by preparatory reverse-phase high-
performance liquid chromatography (HPLC) on a Beckman Gold system using either a 
Waters Delta-Pak 25 × 100 mm, 15 μm 300 Å C18 PrepPak Cartridge reverse-phase column 
or a Varian Dynamax 21.4 × 250 mm Microsorb 8 μm 300 Å C8 reverse-phase column in 
0.1% (w/v) TFA with acetonitrile as the eluent.  The appropriate fractions were lyophilized 
after characterization by analytical HPLC, UV-visible spectroscopy, and matrix-assisted 
laser desorption ionization/time-of-fl ight mass spectrometry (MALDI-TOF-MS) and/or 
electrospray ionization mass spectrometry (ESI-MS).
Conjugates were formed by reacting the isothiocyanate (compounds 1, 3, 6, and 8), 
succinimidyl ester (compounds 2 and 7), or anhydride (compound 10) with the polyamide 
in a solution of DIEA (20 equiv) and DMF for 1 h at room temperature.  Conjugates 4 
and 9 were formed by preactivating isophthalic acid (3.0 equiv) with PyBOP (2.9 equiv, 
Novabiochem) in a solution of DIEA (20 equiv) and DMF at 37°C for 30 min, followed by 
reaction of the activated solution with the polyamide for 1 h at room temperature.  Conjugates 
were deprotected with neat TFA (Halocarbon) and triethylsilane for 30 min at room 
temperature before purifi cation by preparatory reverse-phase HPLC.  Lyophilization of the 
appropriate fractions yielded the polyamide conjugates 1-10, which were characterized as 
described above.  Extinction coeffi cients were calculated according to standard protocols.24 
Chemicals not otherwise specifi ed were from Aldrich.
ImImPyPy-(R)H2Nγ-ImPyPyPy-β-C3-FITC (1).  Cleaved from β-Ala-PAM resin 
with neat 1,3-diaminopropane and conjugated with fl uorescein-5-isothiocyanate (FITC, 
Invitrogen).  UV-vis λmax = 312, 444 nm; ESI-MS m/z 1597.5 (C76H77N24O15S– calculated 
[M-H]– 1597.57)
ImImPyPy-(R)H2Nγ-ImPyPyPy-β-C3-FAM (2).  Cleaved from β-Ala-PAM resin 
with neat 1,3-diaminopropane and conjugated with 5-carboxyfl uorescein, succinimidyl 
ester (5-FAM, SE, Invitrogen).  UV-vis λmax = 315, 444 nm; MALDI-TOF-MS m/z 1568.74 
(C76H78N23O16
+ calculated [M+H]+ 1568.60)
65
ImImPyPy-(R)H2Nγ-ImPyPyPy-β-C3-CPITC (3).  Cleaved from β-Ala-PAM resin 
with neat 1,3-diaminopropane and conjugated with 3-carboxyphenyl isothiocyanate (Trans 
World Chemicals).  UV-vis λmax = 316 nm; ESI-MS m/z 1387.6 (C63H71N24O12S– calculated 
[M-H]– 1387.54)
ImImPyPy-(R)H2Nγ-ImPyPyPy-β-C3-IPA (4).  Cleaved from β-Ala-PAM resin 
with neat 1,3-diaminopropane and conjugated with isophthalic acid.  UV-vis λmax = 315 
nm; MALDI-TOF-MS m/z 1358.66 (C63H72N23O13
+ calculated [M+H]+ 1358.57)
ImImPyPy-(R)H2Nγ-ImPyPyPy-β-Dp (5).  Cleaved from β-Ala-PAM resin with 
neat 3-dimethylamino-1-propylamine.  UV-vis λmax = 315 nm; MALDI-TOF-MS m/z 
1238.88 (C57H72N23O10
+ calculated [M+H]+ 1238.58)
ImImPyPy-(R)H2Nγ-ImPyPyPy-(+)-FITC (6).  Cleaved from oxime resin with neat 
3,3’-diamino-N-methyldipropylamine and conjugated with fl uorescein-5-isothiocyanate 
(FITC, Invitrogen).  UV-vis λmax = 316, 444 nm; ESI-MS m/z 1597.6 (C77H81N24O14S– 
calculated [M-H]– 1597.61)
ImImPyPy-(R)H2Nγ-ImPyPyPy-(+)-FAM (7).  Cleaved from oxime resin with 
neat 3,3’-diamino-N-methyldipropylamine and conjugated with 5-carboxyfl uorescein, 
succinimidyl ester (5-FAM, SE, Invitrogen).  UV-vis λmax = 316, 444 nm; MALDI-TOF-
MS m/z 1568.52 (C77H82N23O15
+ calculated [M+H]+ 1568.64)
ImImPyPy-(R)H2Nγ-ImPyPyPy-(+)-CPITC (8).  Cleaved from oxime resin 
with neat 3,3’-diamino-N-methyldipropylamine and conjugated with 3-carboxyphenyl 
isothiocyanate (Trans World Chemicals).  UV-vis λmax = 316 nm; ESI-MS m/z 1387.4 
(C64H75N24O11S
– calculated [M-H]– 1387.58)
ImImPyPy-(R)H2Nγ-ImPyPyPy-(+)-IPA (9).  Cleaved from oxime resin with neat 
3,3’-diamino-N-methyldipropylamine and conjugated with isophthalic acid.  UV-vis λmax = 
316 nm; MALDI-TOF-MS m/z 1358.31 (C64H76N23O12
+ calculated [M+H]+ 1358.60)
ImImPyPy-(R)H2Nγ-ImPyPyPy-(+)-Ac (10).  Cleaved from oxime resin with neat 
3,3’-diamino-N-methyldipropylamine and conjugated with acetic anhydride.  UV-vis λmax 
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= 316 nm; MALDI-TOF-MS m/z 1252.55 (C58H74N23O10
+ calculated [M+H]+ 1252.60)
4.2.2.  Plasmid construction
Plasmids pCFH6 and pJWP6 were constructed according to 
standard protocols for DNA manipulation.25  Plasmid pCFH6 was 
constructed by annealing the two 87-mer DNA oligonucleotides 5’-
GATCGTGTAATCAATGGTCATAGCTGTGTAATCATTGGTCATAGCTGTGT
AATCACTGGTCATAGCTGTGTAATCAGTGGTCATAGC-3’ and 5’-
AGCTGCTATGACCACTGATTACACAGCTATGACCAGTGATTACACAGCTA
T G A C C A AT G AT T A C A C A G C T AT G A C C AT T G AT T A C A C -
3’ (Integrated DNA Technologies).  Plasmid pJWP6 was 
constructed by annealing the two 91-mer DNA oligonucleotides 5’-
GATCGTGTAATCAAATGGTCATAGCTGTGTAATCATATGGTCATAGCTGT
GTAATCACATGGTCATAGCTGTGTAATCAGATGGTCATAGC-3’ and 5’-
AGCTGCTATGACCATCTGATTACACAGCTATGACCATGTGATTACACAGC
TATGACCATATGATTACACAGCTATGACCATTTGATTACAC-3’.  Annealed 
oligonucleotides were ligated into the BamHI/HindIII (Roche) restriction fragment of 
pUC19 (Sigma).   DNA sequencing of the constructed plasmids was performed at the 
Sequence Analysis Facility at the California Institute of Technology.
 
4.2.3.  Preparation of 5’-32P-end-labeled DNA
The forward primer 5’-AATTCGAGCTCGGTACCCGGG-3’ was 32P-labeled at 
the 5’-end.  The reverse primer 5’-CTGGCACGACAGGTTTCCCGAC-3’ was used to 
amplify plasmids pCFH6 and pJWP6 as previously described.24  PCR products (5’-32P-
end-labeled, 291 bp for pCFH6, 295 bp for pJWP6) were isolated according to standard 
protocols.24
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4.2.4.  Quantitative DNase I footprint titrations
Quantitative DNase I footprint titration experiments were performed on the 5’-
32P-end-labeled PCR products of plasmids pCFH6 and pJWP6 according to standard 
protocols.24  Radiolabeled DNA was equilibrated with polyamide solutions for 14-16 h at 
22°C in a buffer of 10 mM Tris-HCl, 10 mM KCl, 10 mM MgCl2, and 5 mM CaCl2 at pH 
7.0 prior to DNase I cleavage.  Chemical sequencing reactions were performed according 
to published methods.26,27
4.2.5.  Cell cultures
Human cancer cell lines HeLa, MCF7, and PC3 were cultured in a 5% CO2 
atmosphere at 37°C in supplemented DMEM (HeLa, GIBCO) or RPMI medium 1640 
(MCF7 and PC3, GIBCO).9,10  All media were supplemented with 10% fetal bovine serum 
(Omega Scientifi c) and 1% penicillin/streptomycin solution (Mediatech).
4.2.6.  Confocal microscopy
Cell lines were trypsinized (Mediatech) for 5 min at 37°C, centrifuged for 10 min 
at 4°C at 100 g, and resuspended in fresh medium to a concentration of 1.33 × 105 cells/
mL (HeLa) or 3.33 × 105 cells/mL (MCF7 and PC3).9,10  Incubations were performed by 
adding 150 μL of cells into culture dishes equipped with glass bottoms for direct imaging 
(MatTek).  Cells were grown in the glass-bottom culture dishes for 24 h.  The medium was 
then removed and replaced with 147 μL of fresh medium, followed by addition of 3 μL of 
the 100 μM polyamide solution for a fi nal polyamide concentration of 2 μM.  Cells were 
incubated in a 5% CO2 atmosphere at 37°C for 12 h.  Imaging was performed with a 40× 
oil-immersion objective lens on a Zeiss LSM 5 Pascal inverted laser scanning microscope. 
Polyamide-fl uorescein conjugate fl uorescence and visible light images were obtained using 
standard fi lter sets for fl uorescein.9,10
68
4.3.  Results
4.3.1.  DNA binding affi nity and sequence specifi city of polyamide conjugates
Ten hairpin polyamide conjugates were synthesized by solid-phase methods (Figure 
4.1).  Compounds 1-5, synthesized on β-Ala-PAM resin, were of the type ImImPyPy-(R)H2Nγ-
ImPyPyPy-β-C3-R1 (β = β-alanine, C3 = 1,3-diaminopropane linker).  Compounds 6-10, 
synthesized on oxime resin, were of the type ImImPyPy-(R)H2Nγ-ImPyPyPy-(+)-R2 ((+) = 
3,3’-diamino-N-methyldipropylamine linker).  Each series of fi ve compounds contained 
thiourea-linked fl uorescein, amide-linked fl uorescein, thiourea-linked 3-carboxyphenyl, 
amide-linked 3-carboxyphenyl, and control (Dp or Ac) conjugates.
Plasmid pCFH6 was designed to contain four binding sites of the form 5’-
ANTGGTCA-3’ (N = A, T, C, or G) (Figure 4.2).  The four Watson-Crick base pairs were 
permuted at the 5’-end of the 7-bp binding site to test sequence specifi city at the N-2 
position of the C-terminal tail.  Following the results of footprinting experiments on plasmid 
pCFH6 (Figure 4.3 and Table 4.1), plasmid pJWP6 was designed to contain four binding 
sites of the form 5’-NATGGTCA-3’ with permutation at the 5’-end of the 8-bp binding site 
to test sequence specifi city at the N-3 position of the C-terminal tail (Figure 4.2).
Quantitative DNase I footprint titration experiments were performed on the 291 
bp, 5’-32P-end-labeled PCR product of plasmid pCFH6 and the 295 bp, 5’-32P-end-labeled 
PCR product of pJWP6.24  Each polyamide was assayed on a plasmid containing four 
potential match sites in which a single Watson-Crick base pair was permuted.  On plasmid 
pCFH6, the thiourea-linked polyamide-fl uorescein conjugate 1 bound the 7-bp binding 
sites 5’-ATGGTCA-3’ and 5’-TTGGTCA-3’ with equilibrium association constants of 
6.3×109 M-1 and 5.1×109 M-1, respectively (Figure 4.3 and Table 4.1).  Compound 1 bound 
the other two designed sites (C•G and G•C) with Ka = 1.8×10
9 M-1, indicating that this 
molecule exhibits 4-fold specifi city for A•T and 3-fold specifi city for T•A.  The amide-
linked polyamide-fl uorescein conjugate 2 showed decreased binding affi nity but strong 
sequence specifi city, as its equilibrium association constant of 3.2×109 M-1 displayed an 
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3’- T Y A C C A G T -5’
5’- A X T G G T C A -3’
3’- T Y A C C A G T -5’
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+C3R1
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Figure 4.2.  Designed binding sites on plasmids pCFH6 and pJWP6.  Imidazole and pyrrole 
are shown as fi lled and non-fi lled circles, respectively; β-alanine is shown as a diamond; 
the 1,3-diaminopropane linker is shown as “C3”; the 3,3’-diamino-N-methyldipropylamine 
linker is shown as “(+)”; and the chiral diaminobutyric acid turn residue is shown as a 
semicircle connecting the two subunits linked to a half-circle with a plus.
8-fold preference for A•T over C,G.  Both of the carboxyphenyl conjugates 3 and 4 bound 
their match sites with a binding affi nity of greater than 1×1010 M-1 and exhibited similar 
4-fold specifi city.  As expected, the smaller carboxyphenyl conjugates bound more tightly 
than fl uorescein conjugates.  The binding profi les of compounds 3 and 4 were very similar 
even though these conjugates were created with different linkages.  The control compound 
5 had the highest equilibrium association constant in the series, as its Ka = 3.2×109 M-1 
for the A•T site was 5-fold higher than the Ka for the C,G sites.  The A,T preference seen 
in 5 is consistent with the trend observed for the analogous six-ring polyamide ImImPy-
(R)H2Nγ-ImPyPy-β-Dp, which exhibited 23-fold and 11-fold specifi city for A•T and T•A, 
respectively.20  The binding energetics data for compounds 1-4 demonstrate that the 1,3-
diaminopropane linker also displays A,T specifi city.
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5’-GTGTAATCA ATGGTCA TAGCTGTGTAATCA TTGGTCA TAGCTGTGTAATCA CTGGTCA TAGCTGTGTAATCA GTGGTCA TAGC-3’
3’-CACATTAGT TACCAGT ATCGACACATTAGT AACCAGT ATCGACACATTAGT GACCAGT ATCGACACATTAGT CACCAGT ATCG-5’
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Figure 4.3.  Quantitative DNase I footprint titration experiments for polyamide conjugates 
1, 2, and 5 on the 291 bp, 5’-32P-end-labeled PCR product of plasmid pCFH6:  lane 1, 
intact DNA; lane 2, G reaction; lane 3, A reaction; lane 4, DNase I standard; lanes 5-15, 
1 pM, 3 pM, 10 pM, 30 pM, 100 pM, 300 pM, 1 nM, 3 nM, 10 nM, 30 nM, and 100 nM 
polyamide, respectively.  Binding isotherms for the four designed sites are shown below each 
footprinting gel; θnorm values were calculated according to published methods.24  Imidazole 
and pyrrole are shown as fi lled and non-fi lled circles, respectively; β-alanine is shown as a 
diamond; the 1,3-diaminopropane linker is shown as “C3”; the dimethylaminopropylamine 
tail is shown as a half-circle with a plus; and the chiral diaminobutyric acid turn residue is 
shown as a semicircle connecting the two subunits linked to a half-circle with a plus.
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pCFH6 R Linkage 5’-AATGGTCA-3’ 5’-ATTGGTCA-3’ 5’-ACTGGTCA-3’ 5’-AGTGGTCA-3’ 
      
      
1 fluorescein thiourea 6.3 (±1.9)×109 5.1 (±1.7)×109 1.7 (±0.5)×109 1.8 (±0.5)×109
  [4] [3] [1] [1] 
      
2 fluorescein amide 3.2 (±1.1)×109 2.1 (±0.6)×109 4.0 (±1.2)×108 4.1 (±1.0)×108
  [8] [5] [1] [1] 
      
3 carboxyphenyl thiourea 1.3 (±0.5)×1010 1.2 (±0.5)×1010 3.7 (±1.8)×109 4.1 (±1.8)×109
  [4] [3] [1] [1] 
      
4 carboxyphenyl amide 1.5 (±0.4)×1010 1.2 (±0.4)×1010 4.1 (±1.4)×109 4.8 (±1.9)×109
  [4] [3] [1] [1] 
      
5 – – 3.7 (±0.5)×1010 2.5 (±0.1)×1010 8.7 (±1.4)×109 8.0 (±0.7)×109
  [5] [3] [1] [1] 
      
      
6 fluorescein thiourea 1.7 (±0.2)×1010 1.6 (±0.2)×1010 6.8 (±0.3)×109 6.0 (±0.7)×109
  [3] [3] [1] [1] 
      
7 fluorescein amide 6.5 (±1.0)×109 6.6 (±1.2)×109 2.0 (±0.3)×109 9.7 (±2.0)×108
  [7] [7] [2] [1] 
      
8 carboxyphenyl thiourea 8.8 (±1.3)×109 8.8 (±1.0)×109 3.5 (±1.1)×109 2.6 (±0.5)×109
  [3] [3] [1] [1] 
      
9 carboxyphenyl amide 1.0 (±0.2)×1010 1.0 (±0.2)×1010 5.1 (±0.4)×109 3.3 (±0.4)×109
  [3] [3] [1] [1] 
      
10 acetyl amide 3.1 (±0.5)×1010 2.9 (±0.3)×1010 1.5 (±0.1)×1010 1.1 (±0.1)×1010
  [3] [3] [1] [1] 
      
Table 4.1.  Equilibrium association constantsa
a Ka (M
-1) values reported are the mean values from at least three DNase I footprint titration 
experiments.  Assays were performed at 22°C in a buffer of 10 mM Tris-HCl, 10 mM 
KCl, 10 mM MgCl2, and 5 mM CaCl2 at pH 7.0.  Specifi city is indicated in brackets and 
calculated as Ka (site) / Ka (min).
Compounds 6-10 have an additional positive charge due to the protonation of the 
3,3’-diamino-N-methyldipropylamine linker at physiological pH.  The thiourea-linked 
fl uorescein conjugate 6 bound the A•T site with Ka = 1.7×1010 M-1 (3-fold specifi city), and 
the amide-linked fl uorescein conjugate 7 bound the T•A site with Ka = 6.6×109 M-1 (7-fold 
specifi city).  When compared with 1 and 2, oxime compounds 6 and 7 bound DNA more 
tightly but with comparable specifi city.  Compounds 8 and 9 bound A,T sites with Ka = 
8.8×109 M-1  and 1.0×1010 M-1, respectively.  The acetylated control compound 10 displayed 
an equilibrium association constant of 3.1×1010 M-1, and, for all three of these compounds 
8-10, their 3-fold preference for A,T was slightly less than that shown by compounds 3-5. 
These experiments indicate that the 3,3’-diamino-N-methyldipropylamine linker is A,T-
specifi c; however, the linker likely spans the two base pairs 5’-WT-3’.
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Based on the conclusion that both linkers specify for A,T base pairs, plasmid pJWP6 
was designed to test whether the conjugated R group can serve as a recognition element, 
by placing an A•T base pair at the N-2 position and varying the N-3 base pair across the 
four Watson-Crick base pairs.  Control polyamide 5 exhibited the lowest specifi city for T•A 
(4.5×1010 M-1) over G•C (2.7×1010 M-1) (Figure 4.4 and Table 4.2).  The other nine conjugates 
showed at least 2-fold specifi city for A,T, and, as with the previous plasmid, amide-linked 
conjugates displayed stronger specifi city than thiourea-linked compounds.  One highlight 
was the amide-linked fl uorescein compound 7, whose equilibrium association constant of 
6.0×109 M-1 for A•T was nearly an order of magnitude greater than the Ka of 6.8×10
8 M-1 
for G•C.  In general, rational design of the linker and R group leads to the recognition of an 
eighth base pair at the N-3 position.
4.3.2.  Nuclear localization of polyamide-fl uorescein conjugates
Human cancer cell lines HeLa, MCF7, and PC3 were cultured for cell uptake 
studies using confocal laser scanning microscopy.  For compounds 1, 6, and 7, the nuclear 
staining exceeded that of the medium in all cell lines (Table 4.3).  For compound 2, there 
was some nuclear staining in HeLa cells, although it was similar to that of the medium, 
and little nuclear staining was observed in MCF7 and PC3 cells.  The cellular uptake data 
for compound 6 were previously reported.10  Because FITC and FAM were considered 
to be interchangeable previously, the results for compound 7 were expected. However, 
the positive nuclear localization data for the β-alanine-linked fl uorescein conjugate 1 was 
a pleasant surprise, suggesting that 1,3-diaminopropane could be a viable linker for β-
alanine-linked conjugates synthesized on PAM resin.  The mixed results for compound 
2 are a reminder that thiourea and amide linkages are often different in terms of cellular 
uptake as well as sequence specifi city.
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Figure 4.4.  Quantitative DNase I footprint titration experiments for polyamide conjugates 
1, 2, and 5 on the 295 bp, 5’-32P-end-labeled PCR product of plasmid pJWP6:  lane 1, 
intact DNA; lane 2, G reaction; lane 3, A reaction; lane 4, DNase I standard; lanes 5-15, 
1 pM, 3 pM, 10 pM, 30 pM, 100 pM, 300 pM, 1 nM, 3 nM, 10 nM, 30 nM, and 100 nM 
polyamide, respectively.  Binding isotherms for the four designed sites are shown below each 
footprinting gel; θnorm values were calculated according to published methods.24  Imidazole 
and pyrrole are shown as fi lled and non-fi lled circles, respectively; β-alanine is shown as a 
diamond; the 1,3-diaminopropane linker is shown as “C3”; the dimethylaminopropylamine 
tail is shown as a half-circle with a plus; and the chiral diaminobutyric acid turn residue is 
shown as a semicircle connecting the two subunits linked to a half-circle with a plus.
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Table 4.2.  Equilibrium association constantsa
      
pJWP6 R Linkage 5’-AATGGTCA-3’ 5’-TATGGTCA-3’ 5’-CATGGTCA-3’ 5’-GATGGTCA-3’ 
      
      
1 fluorescein thiourea 5.1 (±0.8)×109 5.4 (±1.1)×109 3.6 (±0.7)×109 3.2 (±0.6)×109
  [2] [2] [1] [1] 
      
2 fluorescein amide 3.7 (±1.0)×109 3.5 (±1.4)×109 1.2 (±0.2)×109 8.8 (±1.1)×108
  [4] [4] [1] [1] 
      
3 carboxyphenyl thiourea 1.4 (±0.6)×1010 1.5 (±0.6)×1010 8.3 (±2.3)×109 7.1 (±2.3)×109
  [2] [2] [1] [1] 
      
4 carboxyphenyl amide 1.5 (±0.2)×1010 1.5 (±0.1)×1010 6.1 (±1.1)×109 4.7 (±1.9)×109
  [3] [3] [1] [1] 
      
5 – – 3.1 (±1.5)×1010 4.5 (±1.9)×1010 3.0 (±1.2)×1010 2.7 (±1.2)×1010
  [1] [2] [1] [1] 
      
      
6 fluorescein thiourea 1.6 (±0.4)×1010 2.3 (±0.4)×1010 1.2 (±0.2)×1010 8.9 (±1.1)×109
  [2] [3] [1] [1] 
      
7 fluorescein amide 6.0 (±3.9)×109 4.9 (±3.1)×109 2.1 (±0.6)×109 6.8 (±0.9)×108
  [9] [7] [3] [1] 
      
8 carboxyphenyl thiourea 1.9 (±0.4)×1010 2.2 (±0.4)×1010 1.1 (±0.1)×1010 8.3 (±1.5)×109
  [2] [3] [1] [1] 
      
9 carboxyphenyl amide 3.2 (±0.2)×1010 2.2 (±0.5)×1010 1.1 (±0.1)×1010 5.1 (±1.2)×109
  [6] [4] [2] [1] 
      
10 acetyl amide 3.6 (±0.5)×1010 3.2 (±0.3)×1010 1.4 (±0.1)×1010 1.1 (±0.1)×1010
  [3] [3] [1] [1] 
      
a Ka (M
-1) values reported are the mean values from at least three DNase I footprint titration 
experiments.  Assays were performed at 22°C in a buffer of 10 mM Tris-HCl, 10 mM 
KCl, 10 mM MgCl2, and 5 mM CaCl2 at pH 7.0.  Specifi city is indicated in brackets and 
calculated as Ka (site) / Ka (min).
4.4.  Discussion
DNase I footprinting experiments indicate that hairpin polyamide conjugates 1-4 and 
6-9 have decreased binding affi nity relative to their parent polyamide compounds 5 and 10, 
respectively.  This trend becomes more severe as the steric bulk of the conjugated R group 
increases, so fl uorescein conjugates are impacted more than 3-carboxyphenyl conjugates. 
Control polyamides 5 and 10 bind their preferred match sites with an equilibrium association 
constant of 3×1010 M-1, while 3-carboxyphenyl and fl uorescein conjugates bind in the mid-
109 M-1 range.  The subnanomolar binding affi nities of these conjugates, coupled with 
good sequence specifi city, make these compounds strong leads for continued biological 
applications.
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Table 4.3.  Nuclear localization of polyamide-fl uorescein conjugatesa
    
 Compound Linkage HeLa MCF7 PC3 
    
    
1 thiourea + +  + +  + +  
    
2 amide + – – 
    
6 thiourea + +  + +  + +  
    
7 amide + +  + +  + +  
    
a Uptake profi le of polyamide-fl uorescein conjugates in three cell lines.  + + , Nuclear 
staining exceeds that of the medium; +, nuclear staining less than or equal to that of the 
medium, but still prominent; –, very little nuclear staining, with the most fl uorescence seen 
in the cytoplasm and/or medium.  Imidazole and pyrrole are shown as fi lled and non-fi lled 
circles, respectively; β-alanine is shown as a diamond; the 1,3-diaminopropane linker is 
shown as “C3”; the 3,3’-diamino-N-methyldipropylamine linker is shown as “(+)”; and 
the chiral diaminobutyric acid turn residue is shown as a semicircle connecting the two 
subunits linked to a half-circle with a plus.
For conjugates synthesized on Boc-β-Ala-PAM resin, it appears that the 1,3-
diaminopropane linker is A,T-specifi c, with the C3 linker extending out only one additional 
Watson-Crick base pair, as evidenced by the footprinting of control compound 5.  For oxime 
compounds, the 3,3’-diamino-N-methyldipropylamine linker prefers 5’-WT-3’ base pair 
steps over 5’-GT-3’ or 5’-CT-3’.  In general, β-C3 and 3,3’-diamino-N-methyldipropylamine 
linkers lead to compounds with similar binding affi nities, although they might contain 
different charges at physiological pH.  Notably, amide-linked compounds have higher 
sequence specifi city, and amide-linked fl uorescein conjugates have an especially strong A,T 
preference.  Thus, it is now possible to take advantage of the inherent W-specifi c recognition 
properties of linkers and R groups to design high-affi nity, high-specifi city DNA-binding 
compounds taking into account binding preferences at the N-2 and N-3 positions.
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The positive cellular uptake data is highly encouraging as hairpin polyamide 
conjugates are used in cell culture experiments.  The nuclear localization of compound 
1 suggests that the β-alanine residue is not lethal when the appropriate amine linker 
is utilized, so PAM resin can be used in the synthesis of this class of conjugates going 
forward.  The uptake of compounds 6 and 7 is consistent with the observed trend that 
conjugates synthesized on oxime resin (without the β-alanine residue) tend to localize well 
in human cancer cell lines.  Having the ability to cleave from either resin with different 
linkers broadens the range of cell-permeable hairpin polyamide conjugates that are suitable 
for regulation of gene transcription.
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Chapter 4B
Inhibition of VEGF with β-Alanine-C3-Linked
Hairpin Polyamide Conjugates
This project was done in collaboration with Nicholas Nickols (Dervan group, Caltech).
Nicholas Nickols synthesized polyamide 1.
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Abstract
Hairpin polyamide conjugates synthesized on Boc-β-Ala-PAM resin and cleaved 
with 1,3-diaminopropane have been observed to exhibit favorable nuclear uptake properties 
in human cancer cell lines.  In this study, DNase I footprint titrations indicate that these small 
molecules bind the hypoxia response element 5’-TACGTG-3’ with affi nities of Ka > 3 × 10
9 
M-1.  Polyamide-fl uorescein conjugates in this class of compounds traffi c to the nucleus of 
live HeLa cells.  A series of hairpin polyamide conjugates with the β-alanine-C3 linker was 
assayed by quantitative RT-PCR for effects on hypoxia-inducible transcription of vascular 
endothelial growth factor (VEGF).  Fluorescein and isophthalic acid β-alanine-C3-linked 
polyamide conjugates 2, 4, and 5 are shown to decrease VEGF mRNA expression.  
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4.5.  Introduction
Pyrrole-imidazole polyamides are synthetic ligands that bind the DNA minor groove 
at subnanomolar concentrations in a sequence-specifi c manner.1,2  Polyamide-fl uorophore 
conjugates have been imaged by confocal laser scanning microscopy to determine the 
extent of nuclear localization.3-6  These experiments showed that the use of a fl uorescein 
dye on the amine tail improved uptake.4  Another trend that emerged was that conjugates 
containing the β-alanine linkage exhibited poor cellular uptake across a number of cell 
lines.5,6  For instance, ImImPyPy-γ-ImPyPyPy-(+)-FITC localized to the nucleus of all cell 
lines tested, while ImImPyPy-γ-ImPyPyPy-β-(+)-FITC was excluded from the nucleus.5
However, these studies also included several examples of β-alanine-linked 
polyamide-fl uorescein conjugates that traffi c unaided to the nucleus.5,6  These observations 
suggested that the composition of the tail linker could have a positive effect on uptake.  Recent 
studies on polyamide-fl uorescein conjugates synthesized with Boc-β-Ala-PAM resin using 
a 1,3-diaminopropane linker showed improved nuclear localization.  Specifi cally, imaging 
experiments with β-alanine-C3-linked FAM conjugates containing a WM moiety showed 
that these polyamides localized to the nucleus of HeLa, MCF-7, and PC3 human cancer cell 
lines.7  Furthermore, in Chapter 4A, the hairpin polyamide conjugate ImImPyPy-(R)H2Nγ-
ImPyPyPy-β-C3-FITC was observed to localize to the nucleus of the same three cell lines. 
Interestingly, in this case, the FAM conjugate showed poorer uptake.  These promising 
examples indicate that an uncharged linker could allow the use of Boc-β-Ala-PAM resin in 
the synthesis of cell-permeable hairpin polyamide conjugates suitable for gene regulation. 
A series of hairpin polyamide conjugates 2-5 was synthesized on Boc-β-Ala-PAM 
resin, and 1,3-diaminopropane was used to link a fl uorescein or isophthalic acid moiety to the 
polyamide tail (Figure 4.5).  The DNA binding affi nity of these compounds for the hypoxia 
response element 5’-TACGTG-3’ was determined by DNase I footprint titrations.  Nuclear 
localization of the polyamide-fl uorescein conjugates was imaged in HeLa cells.  Targeting 
of polyamides to the hypoxia response element has been shown to disrupt the binding of 
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hypoxia-inducible factor as measured by reduction in vascular endothelial growth factor 
(VEGF) gene expression.8-10  The activity of β-alanine-C3-linked polyamide conjugates 2-5 
was assayed by quantitative RT-PCR to determine the level of VEGF mRNA transcript.  
4.6.  Materials and methods
4.6.1.  Polyamide synthesis
Polyamides were synthesized with oxime resin (compound 1, Novabiochem) or Boc-
β-Ala-PAM resin (compounds 2-13, Peptides International) according to published manual 
solid-phase synthesis protocols.11,12  For compounds 1-13, N-α-9-fl uorenylmethoxycarbonyl-
N-γ-tert-butoxycarbonyl-D-2,4-diaminobutyric acid (Fmoc-D-Dab(Boc)-OH, Peptides 
International) was used for the turn linkage.  The protected FmocHNγ-turn amine was 
deprotected with 20% piperidine in DMF and reprotected as the Boc derivative with a 
solution of Boc2O (Fluka) and DIEA in DMF.  The Boc-protected resin was cleaved with 
1 mL of the appropriate amine (3,3’-diamino-N-methyldipropylamine, compounds 1, 7, 8; 
1,3-diaminopropane, compounds 2-6, 9-12; 3-dimethylamino-1-propylamine, compound 
13) at 37°C with agitation for 16 h.  Products were purifi ed by preparatory reverse-phase 
high-performance liquid chromatography (HPLC) on a Beckman Gold system using either a 
Waters Delta-Pak 25 × 100 mm, 15 μm 300 Å C18 PrepPak Cartridge reverse-phase column 
or a Varian Dynamax 21.4 × 250 mm Microsorb 8 μm 300 Å C8 reverse-phase column in 
0.1% (w/v) TFA with acetonitrile as the eluent.  The appropriate fractions were lyophilized 
after characterization by analytical HPLC, UV-visible spectroscopy, and matrix-assisted 
laser desorption ionization/time-of-fl ight mass spectrometry (MALDI-TOF-MS) and/or 
electrospray ionization mass spectrometry (ESI-MS).  HPLC analysis was performed on a 
Beckman Gold system equipped with a diode-array detector using a Phenomenex Gemini 
4.6 mm × 250 mm, 5 μm 110 Å C18 reverse-phase column.  UV spectra were measured on 
an Agilent Technologies 8453 UV-vis ChemStation spectrophotometer.  MALDI-TOF-MS 
was carried out on an Applied Biosystems Voyager DE-PRO.
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Conjugates were formed by reacting the isothiocyanate (compounds 1, 2, 4, 7, 9, 
and 11) or succinimidyl ester (compounds 3 and 10) with the polyamide in a solution of 
DIEA (20 equiv) and DMF for 1 h at room temperature.  Conjugates 5, 8, and 12 were 
formed by preactivating isophthalic acid (3.0 equiv) with PyBOP (2.9 equiv, Novabiochem) 
in a solution of DIEA (20 equiv) and DMF at 37°C for 30 min, followed by reaction of 
the activated solution with the polyamide for 1 h at room temperature.  Conjugates were 
deprotected with neat TFA (Halocarbon) and triethylsilane for 30 min at room temperature 
before purifi cation by preparatory reverse-phase HPLC.  Lyophilization of the appropriate 
fractions yielded the polyamide conjugates 1-13, which were characterized as described 
above.  Extinction coeffi cients were calculated according to standard protocols.13  Chemicals 
not otherwise specifi ed were from Aldrich.
CtPyPyIm-(R)H2Nγ-PyImPyPy-β-C3-FITC (2).  Cleaved from β-Ala-PAM resin 
with neat 1,3-diaminopropane and conjugated with fl uorescein-5-isothiocyanate (FITC, 
Invitrogen).  UV-vis λmax = 315, 443 nm; ESI-MS m/z 1633.6 (C76H74ClN22O15S2– calculated 
[M-H]– 1633.48)
CtPyPyIm-(R)H2Nγ-PyImPyPy-β-C3-FAM (3).  Cleaved from β-Ala-PAM resin 
with neat 1,3-diaminopropane and conjugated with 5-carboxyfl uorescein, succinimidyl 
ester (5-FAM, SE, Invitrogen).  UV-vis λmax = 313, 446 nm; MALDI-TOF-MS m/z 1605.40 
(C76H75ClN21O16S
+ calculated [M+H]+ 1604.51)
CtPyPyIm-(R)H2Nγ-PyImPyPy-β-C3-CPITC (4).  Cleaved from β-Ala-PAM 
resin with neat 1,3-diaminopropane and conjugated with 3-carboxyphenyl isothiocyanate 
(Trans World Chemicals).  UV-vis λmax = 309 nm; ESI-MS m/z 1423.4 (C63H68ClN22O12S2– 
calculated [M-H]– 1423.45)
CtPyPyIm-(R)H2Nγ-PyImPyPy-β-C3-IPA (5).  Cleaved from β-Ala-PAM resin 
with neat 1,3-diaminopropane and conjugated with isophthalic acid.  UV-vis λmax = 314 
nm; MALDI-TOF-MS m/z 1394.72 (C63H69ClN21O13S
+ calculated [M+H]+ 1394.48)
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CtPyPyIm-(R)H2Nγ-PyImPyPy-β-C3-NH2 (6).  Cleaved from β-Ala-PAM resin 
with neat 1,3-diaminopropane.  UV-vis λmax = 315 nm; MALDI-TOF-MS m/z 1246.68 
(C55H65ClN21O10S
+ calculated [M+H]+ 1246.46)
CtPyPyIm-(R)H2Nγ-PyImPyPy-β-(+)-FITC (7).  Cleaved from β-Ala-PAM 
resin with neat 3,3’-diamino-N-methyldipropylamine and conjugated with fl uorescein-
5-isothiocyanate (FITC, Invitrogen).  UV-vis λmax = 313, 442 nm; ESI-MS m/z 1704.3 
(C80H83ClN23O15S2
– calculated [M-H]– 1704.56)
CtPyPyIm-(R)H2Nγ-PyImPyPy-β-(+)-IPA (8).  Cleaved from β-Ala-PAM resin 
with neat 3,3’-diamino-N-methyldipropylamine and conjugated with isophthalic acid.  UV-
vis λmax = 316 nm; MALDI-TOF-MS m/z 1465.59 (C67H78ClN22O13S+ calculated [M+H]+ 
1465.55)
The synthesis and characterization of polyamide conjugate 1 has been reported 
previously.8  The synthesis and characterization of polyamide conjugates 9-13 are reported 
in Chapter 4A.
4.6.2.  Quantitative DNase I footprint titrations
pGL2-VEGF-Luc was 5’-end-labeled and amplifi ed as previously described.8,9 
PCR products (5’-end-labeled, 197 bp for pGL2-VEGF-Luc) were isolated according to 
standard protocols.13  Quantitative DNase I footprint titration experiments were performed 
on the 5’-32P-end-labeled PCR products of plasmid pGL2-VEGF-Luc with polyamides 2-
8 according to standard protocols.13  Radiolabeled DNA was equilibrated with polyamide 
solutions for 14-16 h at 22°C in a buffer of 10 mM Tris-HCl, 10 mM KCl, 10 mM MgCl2, 
and 5 mM CaCl2 at pH 7.0 prior to DNase I cleavage.  Chemical sequencing reactions were 
performed according to published methods.14,15  Storage phosphor autoradiography was 
performed on a Molecular Dynamics Typhoon 8600 phosphorimager.  18 MΩ water was 
obtained from an AquaMAX Ultra water purifi cation system, and all buffers were 0.2 μm 
fi ltered.
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4.6.3.  Cell cultures
The human cervical cancer cell line HeLa was cultured in a 5% CO2 atmosphere at 
37°C in supplemented DMEM medium (GIBCO).5,6  DMEM medium was supplemented 
with 10% fetal bovine serum (Omega Scientifi c) and 1% penicillin/streptomycin solution 
(Mediatech).
4.6.4.  Confocal microscopy
Confocal microscopy experiments were performed according to published 
protocols.5,6  HeLa cells were trypsinized (Mediatech) for 5 min at 37°C, centrifuged for 
10 min at 4°C at 100 × g, and resuspended in fresh medium to a concentration of 1.33 × 
105 cells/mL.5,6  Incubations were performed by adding 150 μL of cells into culture dishes 
equipped with glass bottoms for direct imaging (MatTek).  Cells were grown in the glass-
bottom culture dishes for 24 h.  The medium was then removed and replaced with 147 μL 
of fresh medium, followed by addition of 3 μL of the 100 μM solution for a fi nal polyamide 
concentration of 2 μM.  Cells were incubated in a 5% CO2 atmosphere at 37°C for 12-14 h. 
Imaging was performed with a 40× oil-immersion objective lens on a Zeiss LSM 5 Pascal 
inverted laser scanning microscope.  Polyamide-fl uorescein conjugate fl uorescence and 
visible light images were obtained using standard fi lter sets for fl uorescein.5,6
4.6.5.  Quantitative RT-PCR experiments
Quantitative RT-PCR experiments were performed using HeLa cells according to 
published protocols.8,9  For cell culture experiments, HeLa cells were plated in a 24-well 
format with a concentration of 3 × 104 cells/mL in a volume of 500 μL.  Polyamides were 
added to the medium at this time.  Hypoxia was induced with 300 μM desferrioxamine 
mesylate (DFO) after 48 h.  RNA was harvested after 16 h of chemical induction using an 
RNeasy Mini Kit (Qiagen) and reverse transcribed using PowerScript Reverse Transcriptase 
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(Clontech).  Quantitative RT-PCR was performed using SYBR GREEN PCR Master Mix 
(Applied Biosystems) on an Applied Biosystems 7300 Real Time PCR System.  VEGF 
gene expression levels were measured relative to GUSB.
4.7.  Results and discussion
4.7.1.  Polyamide design and synthesis
The hairpin polyamide conjugates shown in Figure 4.5 comprise two polyamide 
cores for match and mismatch experiments.  The synthesis and activity of polyamide 
conjugate 1 have been previously characterized.8-10  Polyamides 2-8 were designed to 
target the hypoxia response element 5’-TACGTG-3’ binding site.  Polyamides 2-6 were 
synthesized with Boc-β-Ala-PAM resin and cleaved with 1,3-diaminopropane to give the 
β-alanine-C3 linker.  Conjugates 2-5 were formed with a fl uorescein or isophthalic acid 
moiety containing a thiourea or amide linkage.  An unconjugated β-alanine-C3 polyamide 
6 was included in the series as a control compound.  Conjugates 7 and 8 incorporate a 
fl uorescein or isophthalic acid moiety with a positively charged β-alanine-triamine linker. 
The synthesis of polyamides 9-13 has been described in Chapter 4A.  These 
compounds bind the sequence 5’-WGGWCW-3’ with affi nities of Ka > 2 × 10
9 M-1.  The 
nuclear localization of the fl uorescein conjugate 9 is excellent across the HeLa, MCF-7, 
and PC3 cell lines tested, whereas the uptake of the FAM conjugate 10 is more limited but 
still nuclear.
4.7.2.  DNase I footprint titrations
The binding affi nities of polyamides 2-8 on the hypoxia response element 5’-
TACGTG-3’ on plasmid pGL2-VEGF-Luc were measured by DNase I footprint titration 
experiments (Figure 4.6 and Table 4.4).  With the exception of polyamide 3, all of the 
compounds in the series have equilibrium association constants of Ka > 3 × 10
9 M-1.  As 
previously observed, the fl uorescein conjugates 2 and 3 exhibit decreased binding affi nities. 
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Figure 4.6.  Quantitative DNase I footprint titration experiments for polyamides 2 and 5 on 
the 197 bp, 5’-32P-end-labeled PCR product of pGL2-VEGF-Luc; lane 1, intact DNA; lane 
2, G reaction; lane 3, A reaction; lane 4, DNase I standard; lanes 5-15, 3 pM, 10 pM, 30 pM, 
100 pM, 300 pM, 1 nM, 3 nM, 10 nM, 30 nM, 100 nM, 300 nM polyamide, respectively. 
Binding isotherms are shown below each footprinting gel; θnorm values were calculated 
according to published methods.13
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Polyamide 5’-TACGTG-3’
2
3
4
5
6
7
8
3.8 (±1.2) × 109
1.0 (±0.3) × 108
1.2 (±0.2) × 1010
1.4 (±0.1) × 1010
1.3 (±0.2) × 1011
3.6 (±0.9) × 1010
2.1 (±0.6) × 1010
Table 4.4.  Equilibrium association constants for polyamides 2-8a
a Ka (M
-1) values reported are the mean values from at least three DNase I footprint titration 
experiments; standard deviations are shown in parentheses.  Assays were performed at 
22°C in a buffer of 10 mM Tris-HCl, 10 mM KCl, 10 mM MgCl2, and 5 mM CaCl2 at pH 
7.0.
In Chapter 4A, the difference between the affi nities of the FITC and FAM conjugates was 
less than two-fold.  In this case, FITC conjugate 2 binds the match site with Ka = 3.8 × 109 
M-1, while the FAM conjugate 3 has an affi nity of 1.0 × 108 M-1.  This 38-fold difference is 
surprising and may be sequence-dependent.  
4.7.3.  Confocal microscopy
The cellular uptake of the β-alanine-C3-linked polyamide-fl uorescein conjugates 
2, 3, and 7 was directly imaged on a confocal laser scanning microscope (Figure 4.7). 
HeLa cells were incubated with 2 μM polyamide for 12-14 h in a 5% CO2 atmosphere at 
37°C prior to imaging.  All three polyamides showed nuclear staining that exceeds that 
of the medium.  This result is encouraging in the case of the FAM conjugate 3 because 
the nuclear localization of the β-alanine-C3-linked FAM conjugate 10 was modest, as 
described in Chapter 4A.  The positive uptake of the β-alanine-triamine-linked fl uorescein 
conjugate 7 suggests that this polyamide core could be more amenable than others in terms 
of localization.  
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32 7
HeLa
Figure 4.7.  Nuclear localization of polyamides in HeLa cells after incubation at 2 μM 
concentration for 12-14 h at 37°C in standard culture media.
 
4.7.4.  Quantitative RT-PCR experiments in HeLa cells
The binding of polyamide 1 to the hypoxia response element results in the 
downregulation of hypoxia-inducible genes, including vascular endothelial growth factor 
(VEGF).8-10  HeLa cells were incubated with 0.2 μM or 1 μM polyamide for 48 h.  After the 
incubation period, hypoxia was induced with 300 μM DFO.  RNA was harvested 16 h after 
induction, and quantitative RT-PCR analysis was performed (Figure 4.8 and Figure 4.9).
The β-alanine-C3-linked hairpin polyamide conjugates 2, 4, and 5 showed 
comparable levels of VEGF mRNA that were decreased relative to the untreated control. 
However, the lead compound 1 remained superior in downregulating the VEGF gene. 
The FAM conjugate 3, which had shown good nuclear localization but decreased binding 
affi nity, showed little activity.  The high-affi nity unconjugated polyamide 6 also displayed 
little effect, consistent with the model that polyamide conjugates exhibit improved nuclear 
localization.  The β-alanine-triamine-linked fl uorescein conjugate 7 showed moderate 
results, while the analogous isophthalic acid conjugate 8 was less effective.  Mismatch 
polyamides 9-13 did not downregulate VEGF expression at the 1 μM concentration. 
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Figure 4.8.  Relative levels of VEGF mRNA expression as measured by real-time 
quantitative RT-PCR.  HeLa cells were treated with fi nal concentration of 1 μM polyamide, 
and hypoxia was induced with 300 μM DFO.
Taken together, these experiments indicate that β-alanine-C3-linked hairpin 
polyamide conjugates targeted to the hypoxia response element downregulate the hypoxia-
inducible VEGF gene in a sequence-specifi c manner.  Polyamide conjugates synthesized on 
Boc-β-Ala-PAM resin should remain viable candidates for cell culture studies.  Judicious 
linker selection is important in determining nuclear localization.
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Chapter 5
Disrupting the Oct4 Octamer DNA Element
with Pyrrole-Imidazole Polyamide Conjugates
This project was done in collaboration with John Phillips, Daniel Harki, and James Puckett 
(Dervan group, Caltech).
John Phillips performed quantitative DNase I footprint titration experiments.  Daniel Harki 
synthesized polyamides 6, 7, and 9-14.  James Puckett synthesized polyamides 7 and 8.
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Abstract
Oct4 is a member of the POU family of transcription factors that is expressed in the 
early stages of the developing embryo and whose activity is exquisitely important in the 
determination of cell fate.  In embryonic stem cells, small changes in Oct4 levels mark the 
boundary between remaining in an undifferentiated state and differentiating into one of the 
cell layers.  The Oct4 octamer binding site, located adjacent to the Sox2 heptamer binding 
site, has been mapped in the enhancer regions of several developmental genes, including 
Sox2, Nanog, and Pou5f1, the gene that encodes Oct4.  Pyrrole-imidazole polyamides are 
synthetic ligands that bind the DNA minor groove at subnanomolar concentrations with 
programmable sequence specifi city.  A series of hairpin polyamide conjugates was designed 
to target the Oct4 octamer DNA element, and quantitative RT-PCR was used to assay the 
mRNA expression levels of Oct4 target genes.  In the P19 mouse embryonal carcinoma 
cell line, polyamide treatment resulted in a decrease in Utf1 mRNA that was comparable to 
that of Oct4 RNA interference-treated cells.  In addition, the Sox2 mRNA level increased 
two-fold when P19 cells were treated with Oct4-targeted polyamide, suggesting that de-
repression had occurred.  When the R1 mouse embryonic stem cell line was incubated 
with polyamide, a decrease in the Utf1 mRNA level and a two-fold increase in the Nanog 
mRNA level were measured by quantitative RT-PCR assay.  These results indicate that 
polyamide conjugates modulate the expression levels of Oct4-driven genes that control the 
determination of cell fate.
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5.1.  Introduction
Embryonic stem (ES) cells are derived from the inner cell mass of the blastocyst, 
one of the earliest stages of embryonic development.1  They are characterized by the 
capacity for symmetrical self-renewal and the potential to differentiate into all three germ 
layers:  ectoderm, endoderm, and mesoderm.1,2  Oct4, Sox2, and Nanog are transcription 
factors that contribute to the pluripotency of ES cells.3  In particular, Oct4 plays a central 
role in ES self-renewal.4-6  Control of Oct4 expression within a tight range is essential 
to maintain pluripotency.7  A less than two-fold increase results in differentiation into 
primitive endoderm and mesoderm, while a 50% decrease causes ES cells to revert to 
trophectoderm.7  The Oct4/Sox2 complex is an important target in regenerative medicine 
as researchers look to reprogram somatic cells by defi ned factors.8-12
Oct4 (encoded by the Pou5f1 gene) belongs to the POU (Pit, Oct, UNC) family of 
transcription factors and binds to an octamer DNA sequence 5’-ATGCAAAT-3’.13  These 
DNA-binding proteins contain two structurally independent domains connected by a 
variable linker of 15 to 56 amino acids in length.13  The POU-specifi c domain is roughly 75 
amino acids in length and binds the 5’-end ATGC, while the POU-homeo domain contains 
approximately 60 amino acids and binds the 3’-end AAAT.13  Oct4 is highly expressed in 
embryonic stem (ES) cells and is downregulated when these cells differentiate.14  
Oct4 octamer binding sites are often found in close proximity to Sox2 heptamer 
elements.14  Oct4 and Sox2 can form a ternary complex with DNA (Figure 5.1).15  The two 
proteins can also bind as a heterodimer in the absence of DNA.14  The enhancers of target 
genes have been mapped in mice, and these regulatory regions contain an Oct4 binding 
site located near Sox2 binding elements.  These genes include Pou5f1 (the gene that 
encodes Oct4), Sox2, Nanog, Utf1, Fbx15, and Fgf4 (Figure 5.1).14  These DNA elements 
are generally found adjacent to one another, but can be separated by 3 bp, as in the Fgf4 
enhancer.
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                            Sox2                 Oct4
 i)  Pou5f1 CTTTGTT---ATGCATCT
 ii)  Sox2 CATTGTG---ATGCATAT
 iii) Nanog CATTGTA---ATGCAAAA
 iv)  Utf1 CATTGTT---ATGCTAGT
 v)  Fbx15 CATTGTT---ATGATAAA
 vi)  Fgf4 CTTTGTTTGGATGCTAAT
Sox2
Oct4
Figure 5.1.  (top) The 2.6 Å X-ray crystal structure of a POU/HMG/DNA ternary complex 
(PDB accession code 1GT0).15  The POU domain of Oct1 is shown in green, and the HMG 
domain of Sox2 is shown in blue.  These two transcription factors interact on the FGF4 
enhancer.  (bottom) The alignment of Sox and Oct elements from mouse target genes known 
to bind Sox2 and Oct4.14  Image rendered by John Phillips using Chimera software.
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The regulatory elements that control the expression of the Pou5f1 gene include a 
proximal enhancer located about 1.2 kb upstream of the transcription start site and a distal 
enhancer located about 2 kb upstream.14  The distal enhancer controls ES cell-specifi c 
expression of Pou5f1 and contains a composite oct-sox element such that Oct4 regulates its 
own expression.14  The Sox2 regulatory region also contains two enhancers.16  It has been 
proposed that the essential function of Sox2 is to stabilize ES cells in a pluripotent state by 
maintaining the requisite level of Oct4 expression.17  It has been shown that increasing the 
level of Sox2 inhibits the endogenous expression of several Oct4-Sox2 target genes.18
Nanog is an Oct4 target gene that works together with Oct4 and Sox2 to control ES 
cell pluripotency.19  The binding sites of Oct4 and Nanog have been globally mapped in 
the mouse ES cell genome by the ChIP-PET method and were found to exhibit substantial 
overlap.20  The oct-sox composite element in the Nanog proximal promoter is centered 175 
bp upstream of the transcription start site.3  Downregulation of Oct4 and Nanog by RNA 
interference was shown to induce differentiation in mouse ES cells.  
The enhancers of the Utf1, Fbx15, and Fgf4 genes also contain Oct4 octamer 
binding elements.  The Utf1 regulatory element selectively binds the Oct4-Sox2 complex 
but not those containing other members of the Oct family.21  The Fbx15 enhancer octamer 
binding element is centered 530 bp upstream of the transcription start site and contains 
a noncanonical 5’-ATGATAAA-3’ sequence.22  In the Fgf4 enhancer, the Oct4 and Sox2 
binding sites are separated by 3 bp.23  The crystal structure in Figure 5.1 contains the Oct4-
Sox2 complex bound on the Fgf4 enhancer.15
Pyrrole-imidazole polyamides bind the minor groove of DNA in a sequence-specifi c 
manner at subnanomolar concentrations.24,25  The empirically derived “pairing rules” allow 
for shape-selective recognition of DNA sequences.24,25  Polyamides designed to target 5’-
WTGCWW-3’ are shown with their putative binding sites in the enhancers of Oct4 target 
genes (Figure 5.2).  For the Pou5f1, Sox2, Nanog, and Utf1 genes, the Oct4 and Sox2 
binding sites are found directly adjacent to one another, but these elements are separated by 
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5’-ATTCCATTGTTATGATAAACGTG-3’
3’-TAAGGTAACAATACTATTTGCAC-5’
sox octFbx15
Fgf4
5’-AACTCTTTGTTTGGATGCTAATGGGA-3’
3’-TTGAGAAACAAACCTACGATTACCCT-5’
sox oct
(+)IPA
+
5’-CCCTCATTGTTATGCTAGTGAAG-3’
3’-GGGAGTAACAATACGATCACTTC-5’
sox octUtf1
(+)IPA
+
Nanog
5’-TGGACATTGTAATGCAAAAGAAG-3’
3’-ACCTGTAACATTACGTTTTCTTC-5’
sox oct
(+)IPA
+
Sox2
5’-CAGCCATTGTGATGCATATAGGA-3’
3’-GTCGGTAACACTACGTATATCCT-5’
sox oct
(+)IPA
+
Pou5f1 (Oct4)
5’-GCACCTTTGTTATGCATCTGCCG-3’
3’-CGTGGAAACAATACGTAGACGGC-5’
sox oct
(+)IPA
+
Figure 5.2.  Ball-and-stick binding model for the hairpin motif with the polyamide bound 
to its target DNA sequence within the enhancer regions of Oct4 target genes, including 
Pou5f1 (the gene that encodes Oct4), Sox2, Nanog, Utf1, Fbx15, and Fgf4.  Imidazole and 
pyrrole are shown as fi lled and non-fi lled circles, respectively; chlorothiophene is shown as 
a square; the 3,3’-diamino-N-methyldipropylamine linker is shown as “(+)”; and the chiral 
3,4-diaminobutyric acid turn residue is shown as a semicircle connecting the two subunits 
with a dashed wedge linking a half-circle with a plus.  The Sox2 heptamer element and the 
Oct4 octamer element are indicated as “sox” and “oct” above the DNA binding site.
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3 bp in the Fgf4 enhancer.  The Fbx15 element differs from the 5’-ATGCAAAT-3’ octamer 
sequence by one base pair and would be a mismatch for the designed polyamide.
5.2.  Results and discussion
5.2.1.  Polyamide design and synthesis
Hairpin pyrrole-imidazole polyamide conjugates are synthetic ligands that bind 
DNA in a sequence-specifi c manner with subnanomolar affi nity.24,25  Polyamides 1-5 were 
designed to bind the DNA sequence 5’-WTGCWW-3’, and their structures are indicated in 
Figure 5.3.  Conjugate 1 contains fl uorescein connected to the polyamide with a thiourea 
linkage to allow direct imaging of cellular uptake by confocal laser scanning microscopy. 
Conjugates 2-5 contain an isophthalic acid moiety connected to the polyamide with an 
amide linkage.  This class of polyamide conjugates has been shown to exhibit improved 
nuclear localization.26  Polyamides 2 and 3 contain a chiral 2,4-diaminobutyric acid turn 
linkage that improves the binding affi nity over the achiral variant without loss of sequence 
specifi city.27  Polyamides 4 and 5 contain a chiral 3,4-diaminobutyric acid turn linkage 
that has been shown to increase the DNA binding affi nity further with some, but not all, 
polyamide cores.28  The acetylated turn linkage used in the design of compounds 1, 3, and 
5 has been shown to improve nuclear localization in some human cancer cell lines.29,30 
Polyamides 1-5 were synthesized on oxime resin according to published manual solid-
phase synthesis protocols.31,32  Fluorescein and isophthalic acid conjugations, as well as 
the subsequent deprotection and acetylation steps, were performed according to published 
methods.26,28-30  Polyamides 6 and 7 were synthesized as mismatch control compounds for 
cell culture experiments and have been previously characterized.28,33
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Figure 5.3.  Structures of polyamide conjugates 1-7.  Imidazole and pyrrole are shown as 
fi lled and non-fi lled circles, respectively; chlorothiophene is shown as a square; the 3,3’-
diamino-N-methyldipropylamine linker is shown as “(+)”; the chiral 2,4-diaminobutyric 
acid turn residue is shown as a semicircle connecting the two subunits with a solid wedge 
linking a half-circle with a plus; and the chiral 3,4-diaminobutyric acid turn residue is 
shown as a semicircle connecting the two subunits with a dashed wedge linking a half-
circle with a plus.
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5.2.2.  DNase I footprint titrations and melting temperature analysis
The equilibrium association constant (Ka) of polyamide 1 was determined by DNase 
I footprint titration experiments on the Oct4 binding site of the phOCT4-EGFP1 plasmid 
obtained from Dr. Wei Cui of the Roslin Institute.34  A partial sequence of this plasmid is 
shown in Figure 5.18.  Polyamide 1 exhibited a binding affi nity of Ka = 8 × 108 M-1 for 
the DNA sequence 5’-ATGCAT-3’ and Ka = 6 × 10
8 M-1 for 5’-ATGCTT-3’ (Figure 5.4). 
These experiments indicate that the acetylated polyamide-fl uorescein conjugate 1 is a high-
affi nity DNA binder that exhibits good selectivity, as no other mismatch binding sites were 
evident in the footprinting gels.  As shown in the footprinting data presented in Chapters 
4A and 4B, fl uorescein conjugation decreases the equilibrium association constant by an 
order of magnitude.
Melting temperature analysis by UV absorption spectrometry was used to assay the 
DNA binding affi nity of polyamides 1-5.  The 12 bp DNA sequence containing the match 
site observed in the DNase I footprint titrations was used for this experiment (Figure 5.5). 
The Tm value for 5’-GAGATGCATGAC-3’ and its complement sequence alone was 53.5°C. 
Polyamide 1 raised the Tm value by 6.0°C, and the reduced steric bulk of the tail moiety 
in polyamide 3 increased the Tm value by 11.4°C.  As expected, the free amine compound 
2 exhibited a higher ΔTm value of 15.5°C.  Polyamides containing the 3,4-diaminobutyric 
acid turn subunit had the highest ΔTm values.  Perhaps surprisingly, acetylated polyamide 
5 exhibited a ΔTm value of 16.7°C that was higher than that of the free amine compound 
2.  Polyamide 4 raised the melting temperature by 19.1°C, indicating that its DNA binding 
affi nity was the largest in the series.
5.2.3.  Cell culture and confocal microscopy
P19 mouse embryonal carcinoma cells were selected as a model system to measure 
the expression of Oct4 target genes in cell culture.  This cell line was obtained from ATCC 
and cultured at 37°C in a 5% CO2 atmosphere according to recommended protocols. 
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Figure 5.4.  Quantitative DNase I footprint titration experiment for polyamide 1 on the 
5’-end-labeled PCR product of plasmid phOCT4-EGFP1:  lane 1, intact DNA; lane 2, G 
reaction; lane 3, A reaction; lane 4, DNase I standard; lanes 5-15, 10 pM, 30 pM, 100 pM, 
300 pM, 1 nM, 3 nM, 10 nM, 30 nM, 100 nM, 300 nM, 1 μM polyamide, respectively. 
Binding isotherms are shown, and θnorm values were calculated according to published 
methods.37 Imidazole and pyrrole are shown as fi lled and non-fi lled circles, respectively; 
chlorothiophene is shown as a square; the 3,3’-diamino-N-methyldipropylamine linker is 
shown as “(+)”; and the chiral 2,4-diaminobutyric acid turn residue is shown as a semicircle 
connecting the two subunits with a solid wedge linking a half-circle with a plus.
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64.9 (0.2) 11.4
70.2 (0.3) 16.7
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Figure 5.5.  DNA melting temperature analysis.  Experiments were performed with a fi nal 
concentration of 2 μM of DNA oligonucleotides and polyamides 1-5 in a buffer of 10 mM 
sodium cacodylate, 10 mM KCl, 10 mM MgCl2, and 5 mM CaCl2 at pH 7.0.  Imidazole and 
pyrrole are shown as fi lled and non-fi lled circles, respectively; chlorothiophene is shown 
as a square; the 3,3’-diamino-N-methyldipropylamine linker is shown as “(+)”; the chiral 
2,4-diaminobutyric acid turn residue is shown as a semicircle connecting the two subunits 
with a solid wedge linking a half-circle with a plus; and the chiral 3,4-diaminobutyric acid 
turn residue is shown as a semicircle connecting the two subunits with a dashed wedge 
linking a half-circle with a plus.  Error values in parentheses indicate standard deviations 
of quadruplicate experiments.
P19 cells were incubated for 12 h with polyamide 1 to determine the extent of nuclear 
localization.  Direct imaging by confocal laser scanning microcopy was used to image 
cellular uptake.  Polyamide 1 was observed to localize to the nucleus of P19 cells (Figure 
5.6).  However, the uptake profi le in HeLa cells was better than that in P19 cells, suggesting 
that high polyamide concentrations would be necessary to see changes in gene expression. 
In Chapter 3, it was observed that a polyamide-fl uorescein conjugate showed higher nuclear 
concentration in U251 cells than in HeLa cells.
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HeLa P19
(+)FITC NHAc
1
Figure 5.6.  Confocal laser scanning microscopy images of polyamide-fl uorescein 
conjugate 1 in HeLa and P19 cell lines.  Cells were incubated with 2 μM polyamide for 
12 h at 37°C in a 5% CO2 atmosphere.  Imidazole and pyrrole are shown as fi lled and 
non-fi lled circles, respectively; chlorothiophene is shown as a square; the 3,3’-diamino-N-
methyldipropylamine linker is shown as “(+)”; and the chiral 2,4-diaminobutyric acid turn 
residue is shown as a semicircle connecting the two subunits with a solid wedge linking a 
half-circle with a plus.
5.2.4.  Quantitative RT-PCR experiments in P19 cells
For cell culture experiments, P19 mouse embryonal carcinoma cells were plated in 
a 24-well format and incubated with polyamides for 48 h.  The time course for this protocol 
is illustrated in Figure 5.7.  At the conclusion of the experiment, RNA was harvested, and 
quantitative RT-PCR was performed to measure the gene expression levels of Oct4 target 
genes relative to the housekeeping gene Gapdh.  Polyamides 2 and 6 were assayed at 10 
μM and 20 μM.  Lower concentrations (2.5 μM and 5 μM) did not change gene expression 
levels.  Polyamide 6 was previously shown to bind the prostate-specifi c antigen (PSA) 
androgen response element and downregulate androgen-induced PSA genes in cultured 
prostate cancer cells.33  Stealth RNAi duplexes from Invitrogen designed to silence the 
Pou5f1 gene, which encodes Oct4, were used as a positive control.  All three duplexes 
were effective in reducing Pou5f1 gene expression levels greater than 80%, and duplex 
110
0 h 24 h 48 h
P19 cells plated
in 24-well format,
apply compound
RNA
harvested
Time course for 48-hour experiment (P19 mouse embryonal carcinoma cells)
Figure 5.7.  Time course for 48-hour incubation experiments with P19 mouse embryonal 
carcinoma cells.  P19 cells were plated in 24-well format at t = 0 h, and compounds were 
applied at this time.  RNA was harvested at the conclusion of the experiment (t = 48 h).
#2 achieved the greatest knockdown effect.  A mismatch Stealth RNAi with medium GC 
content was used as a negative control.
Oct4 mRNA levels were unchanged by polyamides 2 and 6, while the RNAi 
decreased mRNA levels by 90%, as shown in Figure 5.8.  Utf1 mRNA levels decreased 
in the presence of match polyamide 2, as would be expected by the disruption of Oct4 
transcription factor binding at the octamer DNA element in the enhancer region of the Utf1 
gene.  Sox2 and Nanog mRNA levels increased in a dose-dependent manner in the presence 
of polyamide 2.  All four target genes assayed displayed a sequence-specifi c effect, as 
mismatch polyamide 6 at 10 μM and 20 μM concentrations did not change expression 
levels.  
Polyamides 2-5 were assayed at 20 μM to determine whether compounds with 
increased ΔTm values and acetylated turn linkages would show larger changes in gene 
expression levels (Figure 5.9).  Gene expression was largely unchanged in the presence of 
acetylated compounds 3 and 5, suggesting that this class of compounds does not exhibit 
good cellular uptake in P19 cells.  On the other hand, Utf1 mRNA levels decreased in the 
presence of 20 μM of polyamides 2 and 4, which contain a free chiral amine on the turn 
subunit.  Sox2 mRNA increased three-fold when P19 cells were incubated with 20 μM of 
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Figure 5.8.  Quantitative RT-PCR experiments with polyamides 2 and 6 at 10 μM and 20 
μM fi nal concentration with 48 h incubation in P19 mouse embryonal carcinoma cells. 
Stealth RNAi targeted to Pou5f1 (Oct4) and a negative Stealth RNAi control are also 
shown.  The mRNA levels of Pou5f1 (Oct4), Sox2, Nanog, and Utf1 are calculated relative 
to Gapdh, and error bars indicate standard deviations.
polyamide 4.  However, at these high concentrations of polyamide 4, some dead P19 cells 
were evident at the conclusion of the experiment.  
Polyamides 4 and 7 were assayed at lower concentrations of 2.5 μM and 5 
μM to avoid cell toxicity (Figure 5.10).  Polyamide 7 was previously shown to inhibit 
androgen receptor-mediated PSA expression in a prostate cancer cell line.28  Changes in 
gene expression levels at these concentration ranges were similar to those observed with 
match polyamide 2 at 10.μM and 20 μM.  Notably, Utf1 mRNA was decreased to a level 
comparable to that of the RNAi control, and the Sox2 mRNA level increased two-fold.
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Figure 5.9.  Quantitative RT-PCR experiments with polyamides 2-5 at 20 μM fi nal 
concentration with 48 h incubation in P19 mouse embryonal carcinoma cells.  The mRNA 
levels of Pou5f1 (Oct4), Sox2, Nanog, and Utf1 are calculated relative to Gapdh, and error 
bars indicate standard deviations.
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Figure 5.10.  Quantitative RT-PCR experiments with polyamides 4 and 7 at 2.5 μM and 
5 μM fi nal concentration with 48 h incubation in P19 mouse embryonal carcinoma cells. 
Stealth RNAi targeted to Pou5f1 (Oct4) and a negative Stealth RNAi control are also 
shown.  The mRNA levels of Pou5f1 (Oct4), Sox2, Nanog, Utf1, and Fgf4 are calculated 
relative to Gapdh, and error bars indicate standard deviations.
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5.2.5.  Quantitative RT-PCR experiments in R1 mouse ES cells
Based on these results in the model P19 cell line, similar qRT-PCR experiments were 
performed in R1 mouse embryonic stem (ES) cells.  R1 mouse ES cells were maintained 
according to standard protocols by Caltech Genetically Engineered Mouse Services.  In 
addition to compounds 4 and 7, two polyamide cocktails were administered (Figure 5.11). 
Cocktail 1 contained 5 μM each of polyamides 6, 8, 9, and 10.  Cocktail 2 contained 
5 μM each of polyamides 11-14.  The effects of polyamides 8-10 in cell culture have 
been previously reported.28,33,35  The time course for the 48-hour incubation experiment is 
illustrated in Figure 5.12.  At t = 0 h, R1 cells were plated in a 24-well format.  After 24 
hours, the medium was changed, and compounds were applied.  After 48 hours, the medium 
was changed, and compounds were re-applied.  After 72 hours, RNA was harvested.
At the conclusion of the 48-hour incubation, all of the experimental samples 
appeared morphologically similar to the control untreated cells.  Gene expression levels 
were measured by quantitative RT-PCR (Figure 5.13).  Utf1 mRNA levels decreased in 
the presence of the match polyamide 4 but showed a similar effect in the presence of 
mismatch polyamide 7.  Sox2 and Nanog mRNA levels increased in the presence of the 
tested compounds.
An additional experiment with R1 mouse ES cells was designed to increase the 
incubation period to 72 hours, allowing more time for potential phenotypic changes.36 
Instead of harvesting after 72 hours, the medium was changed and compound was re-
applied for a third time (Figure 5.12).  RNA was harvested at t = 96 hours after plating. 
Match polyamide 4 was assayed at 5 μM and 10 μM concentrations to determine whether 
higher polyamide concentration and increased incubation time would modulate gene 
expression further.  Retinoic acid has been shown to chemically induce the differentiation 
of mouse ES cells.  A fi nal concentration of 2 μM retinoic acid was administered to a set 
of wells in a solution of absolute ethanol.  An analogous set of ethanol control wells was 
prepared for comparison.
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Figure 5.11.  Structures of polyamide conjugates 8-14.  Imidazole and pyrrole are shown as 
fi lled and non-fi lled circles, respectively; chlorothiophene is shown as a square; β-alanine 
is shown as a diamond; the 3,3’-diamino-N-methyldipropylamine linker is shown as “(+)”; 
the chiral 2,4-diaminobutyric acid turn residue is shown as a semicircle connecting the two 
subunits with a solid wedge linking a half-circle with a plus; the chiral 3,4-diaminobutyric 
acid turn residue is shown as a semicircle connecting the two subunits with a dashed wedge 
linking a half-circle with a plus.  
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Figure 5.12.  Time course for 48-hour and 72-hour incubation experiments with R1 mouse 
embryonic stem cells.  R1 cells were plated in 24-well format at t = 0 h, and compounds 
were fi rst applied at t = 24 h.  Medium was changed every 24 hours, and compounds were 
re-applied at this time.  RNA was harvested at the conclusion of the experiment (t = 72 h 
for the 48-hour incubation experiment; t = 96 h for the 72-hour incubation experiment).
0 h 24 h 48 h 72 h 96 h
0 h 24 h 48 h 72 h
R1 cells plated
in 24-well format
change medium,
apply compound
change medium,
re-apply compound
RNA
harvested
Time course for 48-hour experiment (R1 mouse embryonic stem cells)
Time course for 72-hour experiment  (R1 mouse embryonic stem cells)
R1 cells plated
in 24-well format
change medium,
apply compound
change medium,
re-apply compound
change medium,
re-apply compound
RNA
harvested
As observed in the previous experiment, Oct4 mRNA levels were unchanged in 
the presence of match polyamide (Figure 5.14).  After 72 hours of incubation with 10 
μM of polyamide 4, Utf1 mRNA levels decreased over 40%.  A comparison of 48-hour 
and 72-hour incubation periods for 5 μM of polyamide 4 indicates that a similar level of 
downregulation was observed at both time points.  Nanog mRNA levels increased two-
fold after 72 hours of incubation with 10 μM of polyamide 4.  Based on a comparison of 
experiments with 5 μM of polyamide 4, Nanog mRNA levels were higher after 48 hours of 
incubation than after 72 hours.  Treatment with 2 μM retinoic acid yielded a 70% decrease 
in Utf1 mRNA levels and a 2.5-fold increase in Nanog mRNA levels.  
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Figure 5.13.  Quantitative RT-PCR experiments with polyamides 4 and 7 at 2.5 μM and 5 
μM fi nal concentration with 48 h incubation in R1 mouse embryonic stem cells.  Cocktail 
1 contains 5 μM each of polyamides 6, 8, 9, and 10.  Cocktail 2 contains 5 μM each of 
polyamides 11-14.  The mRNA levels of Pou5f1 (Oct4), Sox2, Nanog, Utf1, and Fgf4 are 
calculated relative to Gapdh, and error bars indicate standard deviations.
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Figure 5.14.  Quantitative RT-PCR experiments with polyamide 4 at 5 μM and 10 μM 
fi nal concentration with 72 h incubation in R1 mouse embryonic stem cells.  Retinoic acid 
was added as a solution in ethanol to a fi nal concentration of 2 μM.  The mRNA levels of 
Pou5f1 (Oct4), Sox2, Nanog, Utf1, and Fgf4 are calculated relative to Gapdh, and error 
bars indicate standard deviations.
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The cell morphology of polyamide-treated and EtOH-treated cells was similar to 
that of untreated control R1 mouse ES cells.  However, the cell morphology of the retinoic 
acid-treated cells diverged from that of control cells after 24 hours of incubation (Figure 
5.15).  Retinoic acid-treated cells were healthy after 48 hours and remained divergent in 
appearance when compared with control cells (Figure 5.16).  Based on a picture of these 
cells at higher magnifi cation, it appeared that these cells were differentiating.  After 72 
hours of incubation, the polyamide-treated and EtOH-treated cells were healthy and nearly 
confl uent (Figure 5.17).  The morphology of these experimental samples was similar to that 
of the untreated cells.  Retinoic acid-treated cells continued to show a different morphology. 
However, at the conclusion of the 72-hour incubation period, these cells began to look 
unhealthy, and some colonies had begun to lift off the bottom of the plate.  
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24 h
Figure 5.15.  Images of R1 mouse embryonic stem cells after 24 h treatment.  Untreated cell 
samples, as well as samples treated with 10 μM 4, EtOH only, and 2 μM retinoic acid dosed 
in EtOH, are shown following 24 hours of incubation with the compound indicated.
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10 μM 4
48 h
EtOH control
48 h
2 μM retinoic acid
48 h
2 μM retinoic acid (48 h)
(higher magnification)
Figure 5.16.  Images of R1 mouse embryonic stem cells after 48 h treatment.  Untreated 
cell samples, as well as samples treated with 10 μM 4, EtOH only, and 2 μM retinoic acid 
dosed in EtOH, are shown following 48 hours of incubation with the compound indicated. 
A higher magnifi cation image of retinoic acid-treated sample is shown at bottom.
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EtOH control
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72 h
Figure 5.17.  Images of R1 mouse embryonic stem cells after 72 h treatment.  Untreated cell 
samples, as well as samples treated with 10 μM 4, EtOH only, and 2 μM retinoic acid dosed 
in EtOH, are shown following 72 hours of incubation with the compound indicated.
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5.3.  Conclusion and future directions
The gene expression levels of Oct4 target genes that contain an Oct4 transcription 
factor binding site in the enhancer region were assayed by quantitative RT-PCR.  Based 
on melting temperature analysis of a series of polyamides designed to target the DNA 
sequence 5’-WTGCWW-3’, polyamide 4, which contains a free chiral amine on the 3,4-
diaminobutyric turn linkage, exhibits the highest binding affi nity.  After 48 h incubation 
time with 5 μM of polyamide 4 in a P19 mouse embryonal carcinoma cell line, Utf1 mRNA 
levels were decreased by 60%.  However, it was surprising to observe that Sox2 mRNA 
levels were increased two-fold.  After 72 h incubation time with 10 μM of polyamide 
4 in a R1 mouse embryonic stem cell line, Utf1 mRNA levels were decreased by 40%. 
In contrast, Sox2 mRNA levels only increased modestly, and Nanog mRNA levels were 
increased two-fold.  The cell morphology of polyamide-treated samples appeared similar 
to untreated samples by visual inspection.
The treatment of R1 embryonic stem cells with 2 μM retinoic acid chemically induces 
differentiation that was evident after 24 h and 48 h.  While Utf1 downregulation and Nanog 
de-repression were comparable in the retinoic acid-treated and polyamide-treated samples, 
no changes in cell morphology were observed after incubation with polyamide 4 for 72 h. 
Polyamide-induced differentiation of mouse embryonic stem cells may require longer time-
course experiments.  However, the healthy growth of mouse embryonic stem cells when 
incubated with 10 μM of polyamide 4 is an encouraging sign that higher concentrations 
may be tolerated in future experiments.  
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1341-GTGGAGATTCCAGCCAAATCCCAGGCCTGCCCCTCCCCCTCCTCTGAGAG
     CACCTCTAAGGTCGGTTTAGGGTCCGGACGGGGAGGGGGAGGAGACTCTC
  1391-GCCGTCTTCTTGGCAGACAGCAGAGAGATGCATGACAAAGGTGCCGTGAT
       CGGCAGAAGAACCGTCTGTCGTCTCTCTACGTACTGTTTCCACGGCACTA
    1441-GGTTCTGTCCTGGGGATTGAGATGGCTGGGGAGGGGCCTCCTCCTGTTCC
         CCAAGACAGGACCCCTAACTCTACCGACCCCTCCCCGGAGGAGGACAAGG
      1491-GAAGCATGTTCCTCCCACCCCCACCAGGCCCCATAATCTACCTGCCTTTT
           CTTCGTACAAGGAGGGTGGGGGTGGTCCGGGGTATTAGATGGACGGAAAA
        1541-GGGCAGTTAAAGGCCGAGAAGTGAACACAGCTGCAACCCCACTGCCTTGT
             CCCGTCAATTTCCGGCTCTTCACTTGTGTCGACGTTGGGGTGACGGAACA
          1591-AGACCTTCCGGCAGACCTGTGGCAGGTATT
               TCTGGAAGGCCGTCTGGACACCGTCCATAA
EGFP-
OR
F
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C
T3/4-pr
K
an
/N
eo
phOCT4-EGFP1
8068 bp
Figure 5.18.  The partial sequence of plasmid phOCT4-EGFP1.  The equilibrium association 
constant (Ka) of polyamide 1 was determined by DNase I footprint titration experiments 
on the Oct4 binding site of the phOCT4-EGFP1 plasmid obtained from Dr. Wei Cui of the 
Roslin Institute.34 
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5.4.  Materials and methods
5.4.1.  Polyamide synthesis
Polyamides were synthesized with oxime resin (compounds 1-12, Novabiochem) or 
Boc-β-Ala-PAM resin (compounds 13-14, Peptides International) according to published 
manual solid-phase synthesis protocols.31,32  For compounds 1-3, 6, 8, 10, 13, and 14, N-α-
9-fl uorenylmethoxycarbonyl-N-γ-tert-butoxycarbonyl-D-2,4-diaminobutyric acid (Fmoc-
D-Dab(Boc)-OH, Peptides International) was used for the turn linkage.  The protected 
FmocHNγ-turn amine was deprotected with 20% piperidine in DMF and reprotected as the 
Boc derivative with a solution of Boc2O (Fluka) and DIEA in DMF.  For compounds 1 
and 3, the protected BocHNγ-turn amine was deprotected with 20% trifl uoroacetic acid (TFA, 
Halocarbon) in DCM and reprotected as the acetylated derivative with a solution of acetic 
anhydride and DIEA in NMP.  For compounds 2, 6, 8, 10, 13, and 14, the Boc-protected 
amine was left untreated.  For compounds 4, 5, 7, 9, 11, and 12, N-β-benzyloxycarbonyl-N-
γ-tert-butoxycarbonyl-R-3,4-diaminobutyric acid (Z-Dbu(Boc)-OH, Senn Chemicals AG) 
was used for the turn linkage.  For compounds 1-5, the chlorothiophene-imidazole cap was 
added on solid phase as a dimer.  
The acetylated or Boc-protected or Cbz-protected resin was cleaved with 1 mL 
of 3,3’-diamino-N-methyldipropylamine at 37°C with agitation for 16 h.  Products were 
purifi ed by preparatory reverse-phase high-performance liquid chromatography (HPLC) 
on a Beckman Gold system using a Phenomenex Gemini 21.2 mm × 250 mm, 5 μm 
110 Å C18 reverse-phase column in 0.1% (w/v) TFA with acetonitrile as the eluent.  The 
appropriate fractions were lyophilized after characterization by analytical HPLC, UV-
visible spectroscopy, and matrix-assisted laser desorption ionization/time-of-fl ight mass 
spectrometry (MALDI-TOF-MS).  HPLC analysis was performed on a Beckman Gold 
system equipped with a diode-array detector using a Phenomenex Gemini 4.6 mm × 250 
mm, 5 μm 110 Å C18 reverse-phase column.  UV spectra were measured on an Agilent 
Technologies 8453 UV-vis ChemStation spectrophotometer.  MALDI-TOF-MS was carried 
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out on an Applied Biosystems Voyager DE-PRO.
FITC conjugate 1 was formed by reacting fl uorescein-5-isothiocyanate (Invitrogen) 
with the acetylated polyamide in a solution of DIEA (20 equiv) and DMF for 1 h at 
room temperature.  The product was purifi ed by preparatory reverse-phase HPLC, and 
lyophilization of the appropriate fractions yielded the polyamide-fl uorescein conjugate 1, 
which was characterized as described above.
IPA conjugates 2-14 were formed by pre-activating isophthalic acid (IPA, 3.0 equiv) 
with PyBOP (2.9 equiv, Novabiochem) in a solution of DIEA (20 equiv) and DMF at 37°C 
for 30 min, followed by reaction of the activated solution with the polyamide for 1 h at 
room temperature.  For conjugate 3, the product was purifi ed by preparatory reverse-phase 
HPLC, and lyophilization of the appropriate fractions yielded the acetylated IPA conjugate 
3.  For conjugates 2, 6, 8, 10, 13, and 14, conjugates were deprotected with neat TFA and 
triethylsilane for 30 min at room temperature before purifi cation.
For conjugates 4, 7, 9, 11, and 12, the product was purifi ed by solid-phase extraction 
using a Waters SepPak C-18 Light Cartridge following conjugation with isophthalic acid. 
The eluted fractions in acetonitrile and methanol were lyophilized.  The Cbz protecting 
group was removed according to published protocols.28  A 500 nmol fraction of the 
Cbz-protected hairpin polyamide conjugate was dissolved in 450 μL TFA and 50 μL 
trifl uoromethaneaulfonic acid (TFMSA).  After a reaction time of 5 min, the solution was 
fl ash frozen in liquid nitrogen and overlaid with 1 mL DMF.  The thawed solution was 
diluted in 20% aqueous acetronitrile for purifi cation by preparatory reverse-phase HPLC. 
Lyophilization of the appropriate fractions yielded the IPA conjugates 4, 7, 9, 11, and 12.
Conjugate 5 was synthesized by acetylation of conjugate 4, according to published 
protocols.28  Polyamide conjugate 4 was dissolved in 1200 μL DMF.  A mixture of 135 μL 
pyridine and 15 μL acetic anhydride was added, and the reaction was allowed to proceed 
for 30 min at room temperature.  The product was purifi ed by preparatory reverse-phase 
HPLC, and lyophilization of the appropriate fractions yielded the acetylated IPA conjugate 
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5.  For conjugates 1-14, extinction coeffi cients were calculated according to standard 
protocols.37  Chemicals not otherwise specifi ed were from Aldrich.
CtImPyPy-(R)AcHNγ-PyImPyPy-(+)-FITC (1).  Synthesized with 2,4-
diaminobutyric acid turn subunit and conjugated with fl uorescein-5-isothiocyanate (FITC). 
UV-vis λmax = 307, 444 nm; MALDI-TOF-MS m/z 1288.94 (C58H71ClN21O10S+ calculated 
[M+H-FITC]+ 1288.51)
CtImPyPy-(R)H2Nγ-PyImPyPy-(+)-IPA (2).  Synthesized with 2,4-diaminobutyric 
acid turn subunit and conjugated with isophthalic acid (IPA).  UV-vis λmax = 318 nm; 
MALDI-TOF-MS m/z 1394.86 (C64H73ClN21O12S
+ calculated [M+H]+ 1394.52)
CtImPyPy-(R)AcHNγ-PyImPyPy-(+)-IPA (3).  Synthesized with 2,4-diaminobutyric 
acid turn subunit and conjugated with isophthalic acid (IPA).  UV-vis λmax = 314 nm; 
MALDI-TOF-MS m/z 1436.74 (C66H75ClN21O13S
+ calculated [M+H]+ 1436.53)
CtImPyPy-(R)H2Nγ-PyImPyPy-(+)-IPA (4).  Synthesized with 3,4-diaminobutyric 
acid turn subunit and conjugated with isophthalic acid (IPA).  UV-vis λmax = 318 nm; 
MALDI-TOF-MS m/z 1394.76 (C64H73ClN21O12S
+ calculated [M+H]+ 1394.52)
CtImPyPy-(R)AcHNγ-PyImPyPy-(+)-IPA (5).  Synthesized with 3,4-diaminobutyric 
acid turn subunit and conjugated with isophthalic acid (IPA).  UV-vis λmax = 314 nm; 
MALDI-TOF-MS m/z 1436.78 (C66H75ClN21O13S
+ calculated [M+H]+ 1436.53)
The synthesis and characterization of polyamide conjugates 6-14 have been reported 
previously.33,35  
5.4.2.  Quantitative DNase I footprint titrations
Quantitative DNase I footprint titration experiments were performed on the 5’-32P-
end-labeled PCR products of plasmid phOCT4-EGFP1 according to standard protocols.37 
The phOCT4-EGFP1 plasmid was a gift from Dr. Wei Cui of the Roslin Institute.34 
Radiolabeled DNA was equilibrated with a solution of polyamide 1 for 14-16 h at 22°C 
in a buffer of 10 mM Tris-HCl, 10 mM KCl, 10 mM MgCl2, and 5 mM CaCl2 at pH 7.0 
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prior to DNase I cleavage.  Chemical sequencing reactions were performed according to 
published methods.38,39  Storage phosphor autoradiography was performed on a Molecular 
Dynamics Typhoon 8600 phosphorimager.  18 MΩ water was obtained from an AquaMAX 
Ultra water purifi cation system, and all buffers were 0.2 μm fi ltered.
5.4.3.  UV absorption spectrophotometry
Melting temperature analysis was performed according to published protocols.28 
UV absorption analysis was performed on a Varian Cary 100 spectrophotometer.  Analysis 
was performed in a degassed aqueous buffer of 10 mM sodium cacodylate, 10 mM 
KCl, 10 mM MgCl2, and 5 mM CaCl2 at pH 7.0.  The 12 bp DNA oligonucleotides 5’-
GAGATGCATGAC-3’ and 5’-GTCATGCATCTC-3’ were obtained with HPLC purifi cation 
from Integrated DNA Technologies.  The DNA oligonucleotides and polyamides 1-5 were 
mixed in 1:1 stoichiometry to a fi nal concentration of 2 μM in a volume of 1 mL for 
each experiment.  Prior to analysis, samples were heated to 90°C and cooled to a starting 
temperature of 25°C with a heating or cooling rate of 5°C/min for each ramp.  Denaturation 
profi les were recorded at λ = 260 nm from 25°C to 90°C with a heating rate of 0.5°C/min. 
The reported melting temperatures were defi ned as the maximum of the fi rst derivative of 
the denaturation profi le.
5.4.4.  Cell cultures
Cell lines were cultured in a 5% CO2 atmosphere at 37°C.  The human cervical cancer 
cell line HeLa and the mouse embryonal carcinoma cell line P19 were obtained from ATCC 
and cultured according to recommended protocols.  HeLa cells were cultured in DMEM 
medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS, Omega Scientifi c) 
and 1% penicillin/streptomycin solution (Mediatech).29,30  P19 cells were cultured in Alpha 
Minimum Essential Medium with ribonucleosides and deoxyribonucleosides (Invitrogen) 
supplemented with 7.5% bovine calf serum (Omega Scientifi c) and 2.5% fetal bovine 
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serum.  R1 mouse embryonic stem cells were cultured according to standard protocols by 
Caltech Genetically Engineered Mouse Services.  The R1 mouse embryonic stem cell line 
was obtained from the Nagy lab, where they were developed.
5.4.5.  Confocal microscopy
Confocal microscopy experiments were performed according to published 
protocols.29,30  Cell lines were trypsinized (Mediatech) for 5 min at 37°C, centrifuged for 
10 min at 4°C at 100 × g, and resuspended in fresh medium to a concentration of 1.33 × 
105 cells/mL.  Incubations were performed by adding 150 μL of cells into culture dishes 
equipped with glass bottoms for direct imaging (MatTek).  Cells were grown in the glass-
bottom culture dishes for 24 h.  The medium was then removed and replaced with 147 
μL of fresh medium, followed by addition of 3 μL of the 100 μM solution of polyamide-
fl uorescein conjugate 1 for a fi nal polyamide concentration of 2 μM.  Cells were incubated 
in a 5% CO2 atmosphere at 37°C for 12 h.  Imaging was performed with a 63× oil-immersion 
objective lens on a Zeiss LSM 5 Pascal inverted laser scanning microscope.  Polyamide-
fl uorescein conjugate fl uorescence and visible light images were obtained using standard 
fi lter sets for fl uorescein.29,30
5.4.6.  Quantitative RT-PCR experiments
For cell culture experiments, P19 mouse embryonal carcinoma cells were plated in a 
24-well format with a concentration of 5 × 104 cells/mL in a volume of 500 μL.  Polyamides 
were added to the medium at this time as a solution in water.  RNA was harvested after 48 
h incubation using an RNeasy Mini Kit (Qiagen) and reverse transcribed using SuperScript 
II Reverse Transcriptase (Invitrogen).  Quantitative RT-PCR was performed using SYBR 
GREEN PCR Master Mix (Applied Biosystems) on an Applied Biosystems 7300 Real 
Time PCR System.  Gene expression levels were measured relative to Gapdh.
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R1 mouse embryonic stem cells were cultured according to standard protocols 
by Caltech Genetically Engineered Mouse Services.  The R1 mouse embryonic stem cell 
line was obtained from the Nagy lab, where they were developed.  R1 mouse embryonic 
stem cells were plated in a 24-well format on a feeder layer of mouse primary fi broblasts. 
Polyamides were added to the medium as a solution in water.  Cocktail 1 contains 5 μM 
each of polyamides 6, 8, 9, and 10.  Cocktail 2 contains 5 μM each of polyamides 11-14. 
Retinoic acid (Fluka) was added to the medium as a solution in ethanol.  As a control, an 
equivalent volume of ethanol without retinoic acid was added to the medium.  RNA was 
harvested after 48 h or 72 h using the same procedure described above.
Stealth RNAi transfection experiments were performed according to recommended 
protocols for P19 cells from Invitrogen.  For Oct4 (Pou5f1) Stealth RNAi experiments, 
P19 cells were plated in a 24-well format with a concentration of 1 × 105 cells/mL in a 
volume of 400 μL growth medium without antibiotics one day before transfection.  For 
each transfection sample, 50 pmol of Stealth RNAi was diluted in 50 μL of Opti-MEM I 
Reduced Serum Medium.  Separately, 1 μL of Lipofectamine 2000 was diluted in 50 μL of 
Opti-MEM I Reduced Serum Medium and incubated for 15 min at room temperature.  The 
diluted Stealth RNAi and Lipofectamine 2000 solutions were combined and incubated for 
15 min at room temperature before addition to each well.
Stealth RNAi for the Pou5f1 gene was obtained from Invitrogen.  Duplex #1 
contained the 25 bp RNA oligonucleotides 5’-CCAAUGCCGUGAAGUUGGAGAAGGU-
3’ and 5’-ACCUUCUCCAACUUCACGGCAUUGG-3’.  Duplex #2 contained the 
25 bp RNA oligonucleotides 5’-CCCGGAAGAGAAAGCGAACUAGCAU-3’ and 
5’-AUGCUAGUUCGCUUUCUCUUCCGGG-3’.  Duplex #3 contained the 25 bp 
RNA oligonucleotides 5’-CCAAUCAGCUUGGGCUAGAGAAGGA-3’ and 5’-
UCCUUCUCUAGCCCAAGCUGAUUGG-3’.  While all three Stealth RNAi duplexes 
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achieved knockdown of the gene of interest, duplex #2 was the most effective.  A negative 
Stealth RNAi containing medium GC content (Invitrogen, Lot #434330) was used as a 
control.
5.4.7.  Primers for quantitative RT-PCR
The following sets of primers were used for quantitative RT-PCR experiments. 
Oligonucleotides were obtained from Integrated DNA Technologies in LabReady format 
normalized to 100 μM in IDTE pH 8.0.  PCR amplicons were analyzed by gel electrophoresis 
on a 2% agarose gel (Invitrogen) stained with SYBR Gold (Invitrogen) and imaged on a 
Molecular Dynamics Typhoon 8600.  PCR amplifi cation effi ciency and dissociation curve 
analysis were performed as recommended by Applied Biosystems.
Gapdh_03_L:  5’-CGTCCCGTAGACAAAATGGT-3’ (20 bp, 36-55)
Gapdh_03_R:  5’-TTGATGGCAACAATCTCCAC-3’ (20 bp, 126-145)
110 bp amplicon
Pou5f1_02_L:  5’-GTTGGAGAAGGTGGAACCAA-3’ (20 bp, 415-434)
Pou5f1_02_R:  5’-TCTTCTGCTTCAGCAGCTTG-3’ (20 bp, 490-509)
95 bp amplicon
Sox2_01_L:  5’-GCACATGAACGGCTGGAGCAACG-3’ (23 bp, 900-922)
Sox2_01_R:  5’-TGCTGCGAGTAGGACATGCTGTAGG-3’ (25 bp, 1082-1106)
207 bp amplicon
Nanog_01_L:  5'-TCTTCCTGGTCCCCACAGTTT-3' (21 bp, 227-247)
Nanog_01_R:  5'-GCAAGAATAGTTCTCGGGATGAA-3' (23 bp, 304-326)
100 bp amplicon
Utf1_01_L:  5’-GTCCCTCTCCGCGTTAGC-3’ (18 bp, 531-548)
Utf1_01_R:  5’-GGAAGAACTGAATCTGAGCG-3’ (20 bp, 620-639)
109 bp amplicon
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Utf1_02_L:  5'-TGTCCCGGTGACTACGTCT-3' (19 bp, 102-120)
Utf1_02_R:  5'-CCCAGAAGTAGCTCCGTCTCT-3' (21 bp, 216-236)
135 bp amplicon
Fbx15_01_L:  5’-TGCCAATTGTTGGGAGTACA-3’ (20 bp, 111-130)
Fbx15_01_R:  5’-CATGCTGCTTCGTGACAGAT-3’ (20 bp, 184-203)
93 bp amplicon
Fbx15_04_L:  5'-TGTTAGAGGCTCATCTGTCACG-3' (22 bp, 172-193)
Fbx15_04_R:  5'-GATGGCATTCTGTCCAGGGAT-3' (21 bp, 256-276)
105 bp amplicon
Fgf4_02_L:  5'-GTGTGCCTTTCTTTACCGACG-3' (21 bp, 547-567)
Fgf4_02_R:  5'-CTGAGGGCCATGAACATACCG-3' (21 bp, 632-652)
106 bp amplicon
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A.1.  Background
The incorporation of fl uorine into pyrrole-imidazole polyamides as a recognition 
element in the DNA minor groove has been demonstrated at an internal position as well 
as in the N-terminal cap position.  The pairing of α-fl uoro-β-alanine side-by-side with β-
alanine in the 2-β-2 hairpin motif produces little (1.4-fold) specifi city for T•A over A•T.1 
In addition, there was a 30-fold decrease in binding affi nity relative to the β/β pairing.1  At 
the N-terminal cap position, 3-fl uorothiophene has been paired across from Py in an eight-
ring hairpin polyamide to produce 3-fold specifi city for T•A over A•T.2  Synthetic efforts 
towards an internal N-methyl-3-fl uoropyrrole monomer have been reported.3
The second-generation fused heterocycles provide an additional scaffold for the 
incorporation of fl uorine into polyamides.  The fused heterocycle hydroxybenzimidazole 
paired with Py in an eight-ring hairpin polyamide recognizes T•A in the DNA minor groove.4 
The pyrrole-fl uoropyrrole dimer 1 and the pyrrole-fl uorobenzimidazole dimer 2 present the 
same atomic connectivity along the recognition surface of the polyamide (Figure A.1).4 
Therefore, the fl uorobenzimidazole heterocycle was proposed as a synthetic target.  
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Figure A.1.  The pyrrole-fl uoropyrrole dimer 1 and the pyrrole-fl uorobenzimidazole dimer 
2 present the same atomic connectivity along the recognition edge.4
Figure A.2.  Coupling of 3 and 4, followed by condensation, was envisioned for the 
synthesis of the intermediate 5.4  Fluorodiamine 4 was the key synthetic target.
Figure A.3.  Reactions attempted to achieve the desired tetrasubstitution of 4.
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A.2.  Synthetic efforts
It was envisioned that pyrrole-fl uorobenzimidazole dimer 2 could be synthesized 
by an HBTU coupling, followed by condensation, of NO2-Py-COOH monomer 3 and 
fl uorodiamine 4 to give compound 5 (Figure A.2).4  The intermediate 5 could be reduced, 
Boc-protected, and saponifi ed to give the Boc-protected amino acid 2 suitable for solid-
phase coupling.4  For this synthetic route, the fl uorodiamine methyl ester 4 was the key 
synthetic target.  
Figure A.3 illustrates reactions that were attempted to achieve the desired 
tetrasubstitution of synthetic target 4.   Two sets of nitration conditions were attempted 
on starting material 6, which was available in three steps from commercially available 
2-fl uoro-4-nitrotoluene (Aldrich).5-7  Nitric acid treatment did not yield nitration at the 
sterically hindered 3-position as in structure 7.  The use of nitronium tetrafl uoroborate in an 
attempt to form structure 8 resulted in a defl uorinated product, as no peaks were observed 
in the 19F NMR spectrum.  A copper-catalyzed direct amination with methoxylamine of 
starting material 95 also resulted in a defl uorinated product.8  An attempt to use fl uorine as 
a directing group in ortho-lithiation did not result in the synthesis of structure 12.9  
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